Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,19696,31,1.03 [0.15-7.26],0.9764780181835584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,19169,30,0.78 [0.40-1.53],0.4696039199403058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,22482,31,1.27 [0.73-2.21],0.3990809248728709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,19070,31,0.78 [0.29-2.11],0.6198184000026188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,22357,31,0.75 [0.43-1.29],0.2974331767091699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,22482,31,1.00 [0.62-1.61],0.9944285968133988
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,19671,31,1.09 [0.86-1.37],0.4835217109297961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,19070,31,0.80 [0.46-1.37],0.4103114433056597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22075,32,0.90 [0.61-1.34],0.6041238918308829
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19289,30,0.53 [0.24-1.15],0.1083520760478043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19667,31,0.87 [0.58-1.29],0.484262960900383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,22384,34,1.85 [0.62-5.50],0.2662497122495073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,19671,31,2.69 [0.96-7.52],0.0587428888279357
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,22185,33,0.65 [0.31-1.36],0.2557351374826659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,19255,29,2.48 [1.19-5.14],0.0151280052028325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,19567,30,0.76 [0.56-1.03],0.0791361758304364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22588,34,1.35 [0.81-2.24],0.2513504197332745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,19118,29,1.16 [0.55-2.47],0.6943598855301107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,22696,34,1.21 [0.48-3.08],0.6903001667066095
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,22748,33,1.17 [0.72-1.92],0.526793002711571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,19561,30,0.89 [0.34-2.29],0.8026261551412414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,19118,29,0.85 [0.30-2.37],0.7511756587822533
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,19070,31,0.50 [0.15-1.64],0.2502018500802482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",22185,33,1.39 [0.78-2.47],0.2674903426283853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,19070,31,1.29 [0.74-2.27],0.3683370683077017
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,22160,32,1.12 [0.46-2.74],0.797561677757441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,22401,31,2.48 [0.71-8.64],0.1542885900809948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,22588,34,1.27 [0.78-2.06],0.3343621710683871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19070,31,1.30 [0.72-2.34],0.3825099771557313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,19171,28,0.86 [0.49-1.50],0.58729742744665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,22835,33,1.26 [0.54-2.95],0.5992438639379957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,22431,34,2.52 [1.41-4.50],0.0017231919835069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19118,29,1.44 [0.68-3.07],0.3444730615599628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22185,33,3.70 [1.37-9.97],0.0097091399497822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22436,31,1.95 [0.78-4.86],0.1531600724864615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22835,33,0.62 [0.30-1.29],0.2011227670285748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22745,32,10.81 [6.38-18.31],8.414300644325539e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19567,30,2.35 [0.92-6.01],0.0756076134266973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19118,29,0.87 [0.27-2.82],0.811393752461448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22858,34,2.39 [0.61-9.29],0.2089942886232996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22482,31,1.00 [0.50-2.02],0.9917826106129078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22185,33,1.02 [0.37-2.86],0.9638897644619272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19118,29,1.84 [0.88-3.83],0.1039120038813202
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22656,33,0.94 [0.48-1.86],0.8619347954893534
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,19662,30,2.32 [0.84-6.39],0.1042469438053294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,19169,30,1.04 [0.22-4.88],0.9584917139555624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,19667,31,0.76 [0.31-1.83],0.5342211625400545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22075,32,0.76 [0.25-2.30],0.6315208569918761
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,19255,29,0.80 [0.48-1.34],0.4045161737238177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,22401,31,0.64 [0.24-1.71],0.3738890927088808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,19255,29,1.62 [0.63-4.21],0.3195127095594735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,19567,30,2.21 [1.32-3.70],0.0024350470386246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,22689,32,6.04 [2.57-14.22],3.8416447145424135e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,22751,34,4.10 [2.64-6.39],3.9129371449255815e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,19667,31,1.12 [0.35-3.58],0.8468865702629325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,22482,31,1.58 [1.11-2.26],0.0121177925218355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,22588,34,3.42 [1.14-10.31],0.0286005947044647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,19061,30,0.91 [0.53-1.55],0.7201407072924917
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,19255,29,1.28 [0.83-1.96],0.26334751324549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22185,33,1.04 [0.72-1.49],0.8466947580657044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,19696,31,0.84 [0.51-1.39],0.4983624319961525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,22787,33,0.80 [0.26-2.50],0.7013983279697098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,19070,31,0.78 [0.43-1.41],0.4120846764853195
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,19255,29,1.07 [0.71-1.60],0.759801185816386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFM,Afamin,19696,31,1.43 [0.24-8.69],0.697401700440438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,22374,31,1.58 [1.02-2.47],0.042001677643069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,19061,30,1.16 [0.78-1.74],0.4583324281012098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,22537,32,0.78 [0.36-1.69],0.524448176174665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,21828,31,0.84 [0.62-1.15],0.2842188317064575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,22035,32,0.74 [0.42-1.30],0.2896093177206392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,22689,32,1.32 [0.52-3.33],0.5589619499898616
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,22835,33,0.95 [0.53-1.69],0.8564758709563453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,19671,31,0.61 [0.34-1.09],0.0979510202243294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,22588,34,1.13 [0.77-1.64],0.5279216121524464
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,22588,34,1.16 [0.75-1.79],0.5088130059449301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,19169,30,2.42 [1.11-5.28],0.0263774728629598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,19169,30,1.01 [0.30-3.43],0.9860361297438778
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19561,30,0.60 [0.30-1.19],0.1434256677270023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,19671,31,3.92 [1.46-10.54],0.0067686458073932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,22560,33,1.20 [0.85-1.69],0.2982933956050646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",19121,30,0.68 [0.38-1.19],0.1779410245929494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,22075,32,0.74 [0.41-1.37],0.3404760556099193
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,19169,30,0.65 [0.29-1.47],0.3027612472127064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22437,31,0.95 [0.70-1.29],0.7397379330256757
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,22588,34,0.95 [0.60-1.53],0.8470310474128199
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",19628,31,0.75 [0.54-1.04],0.0852699604868428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,19255,29,2.29 [1.10-4.76],0.0266333490223058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,22075,32,0.71 [0.47-1.09],0.1180737817671193
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,19121,30,1.13 [0.66-1.93],0.6475573897791759
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,22185,33,0.53 [0.25-1.11],0.0935585865081745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,19118,29,0.74 [0.41-1.33],0.31245818000936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,22025,31,0.87 [0.54-1.41],0.5732758395766963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,19637,31,0.86 [0.66-1.14],0.2939052129866711
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,21967,32,0.71 [0.40-1.26],0.2473699090651124
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,22858,34,17.10 [4.44-65.82],3.645966135940762e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,22595,33,1.38 [0.83-2.28],0.2168817162623237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",19561,30,0.68 [0.27-1.66],0.393076369459212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22514,32,1.09 [0.71-1.68],0.6985902006066155
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19637,31,1.28 [0.67-2.47],0.4583596328895918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,19289,30,1.20 [0.64-2.24],0.5688310553358662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,19118,29,0.99 [0.74-1.32],0.9379164131272276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",22482,31,1.13 [0.81-1.58],0.4615308283706222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,22160,32,1.92 [1.16-3.16],0.0105274871157939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,22754,33,0.63 [0.14-2.96],0.5613705275982639
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19662,30,1.16 [0.30-4.54],0.8325603293108741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,22025,31,0.60 [0.33-1.09],0.0958701713800915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,19121,30,1.09 [0.57-2.07],0.801847142091367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,22482,31,2.74 [0.66-11.33],0.1646130445728961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,22160,32,0.89 [0.45-1.75],0.7430573066680146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,19255,29,0.98 [0.41-2.38],0.9730526304540992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,19503,30,0.57 [0.22-1.45],0.2377345056109999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,19628,31,1.15 [0.73-1.82],0.5367251594333906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18402,28,0.79 [0.36-1.74],0.5619908227013861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,21689,31,0.96 [0.48-1.91],0.90979527114895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,21036,31,0.96 [0.48-1.90],0.9012496890632288
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,22505,34,0.73 [0.29-1.83],0.4985256715082495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,22507,32,0.79 [0.55-1.13],0.195332424215446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,22787,33,1.23 [0.55-2.75],0.6213515402569869
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,22283,33,0.75 [0.26-2.17],0.5944632782281556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,22622,32,1.44 [0.67-3.11],0.3507954105265455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,22573,34,0.69 [0.30-1.58],0.3775222751058242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,22650,32,0.88 [0.44-1.77],0.7298424524254817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,22787,33,0.80 [0.34-1.88],0.6134835529728776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,19070,31,0.64 [0.33-1.22],0.1747228034327249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19118,29,0.87 [0.55-1.38],0.5568603317778573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,18973,28,0.65 [0.32-1.32],0.2337386238937348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,22075,32,0.91 [0.51-1.62],0.7502667620631054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19169,30,0.60 [0.19-1.90],0.3844070374573505
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,22609,34,0.53 [0.17-1.66],0.2749716924691019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,19129,28,1.24 [0.61-2.52],0.5538798000567868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,22025,31,0.83 [0.54-1.26],0.3763326165462495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,22517,32,0.57 [0.39-0.83],0.0038558530582333
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,18877,29,1.64 [1.18-2.28],0.0032044548503385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,22745,32,0.64 [0.41-1.00],0.0484401915870063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,22472,34,0.87 [0.56-1.33],0.5119468097635076
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,21965,31,0.69 [0.23-2.04],0.4961973992162116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],22160,32,0.40 [0.17-0.93],0.0338252089933552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,22650,34,1.04 [0.38-2.83],0.9356444810660824
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,19561,30,0.83 [0.53-1.31],0.4207198593122385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,19121,30,1.01 [0.49-2.10],0.9718959284211044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,19567,30,0.80 [0.50-1.28],0.3523434476737656
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,19628,31,0.98 [0.47-2.04],0.9563506406172878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22482,31,1.72 [1.04-2.84],0.0344050356509235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,19515,31,0.80 [0.31-2.09],0.6551198637134985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22714,33,2.44 [1.69-3.53],2.043909267267013e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,22588,34,1.38 [0.78-2.43],0.2665740036477944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,19696,31,1.11 [0.33-3.71],0.8635000528529037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,19671,31,1.08 [0.53-2.20],0.8335226518716767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,19696,31,1.09 [0.44-2.68],0.850726763019062
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,19671,31,3.29 [0.83-13.04],0.0903052753993668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,19169,30,0.66 [0.30-1.45],0.305698575626455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,19652,31,1.06 [0.41-2.72],0.9097522273314668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,18785,30,1.27 [0.69-2.36],0.4418443014137262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,19696,31,1.02 [0.65-1.61],0.9193389322253688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,19671,31,0.65 [0.27-1.56],0.3387445178015379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,22595,33,0.96 [0.40-2.29],0.92939537276276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,19671,31,0.86 [0.49-1.51],0.6000825912904886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,22613,34,0.68 [0.40-1.14],0.1435652699990604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,22561,33,0.70 [0.44-1.12],0.1390510172893373
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,19255,29,0.76 [0.56-1.04],0.0869169913763434
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,22405,30,1.27 [0.63-2.57],0.5000745383723115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,19289,30,0.62 [0.34-1.12],0.1128744041285698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,22482,31,0.88 [0.43-1.84],0.7426542014948008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,19567,30,0.81 [0.59-1.11],0.1873885060762994
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,19637,31,0.96 [0.58-1.59],0.8732542147301502
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,22491,32,1.24 [0.69-2.22],0.4699577152875197
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",19561,30,0.89 [0.38-2.06],0.7842172338513944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,22075,32,0.98 [0.49-1.96],0.9602545406227326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,22075,32,1.50 [0.98-2.30],0.0629281658694277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,19289,30,0.38 [0.09-1.59],0.1867556203867078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,19255,29,0.83 [0.53-1.30],0.4136802393889776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,18973,28,0.74 [0.42-1.30],0.2913241308316343
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,19628,31,0.88 [0.60-1.28],0.4929309601652365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,19637,31,1.12 [0.77-1.61],0.5545384642099896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,22547,32,0.84 [0.62-1.14],0.2624858358524469
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,19061,30,0.92 [0.56-1.51],0.7360862136007424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,19061,30,0.58 [0.22-1.54],0.2723801273220583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,22025,31,1.60 [1.08-2.36],0.0181423681798531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,19070,31,0.74 [0.43-1.28],0.2814282909945595
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19070,31,0.88 [0.37-2.09],0.7739891551504987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,19061,30,1.12 [0.70-1.79],0.648424334062577
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,22160,32,0.89 [0.37-2.17],0.8020896619066575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19070,31,0.53 [0.20-1.38],0.1911642255085107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,22595,33,1.18 [0.60-2.31],0.6299708048837471
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,22482,31,0.93 [0.52-1.68],0.8127241890801201
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,22650,34,1.37 [0.55-3.43],0.4954504080651712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,19061,30,0.87 [0.47-1.62],0.6573353423992523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,22160,32,0.35 [0.13-0.94],0.0369333279503897
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,19478,29,1.36 [0.74-2.50],0.3250054815037019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,22436,31,0.84 [0.48-1.47],0.543536435129736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,22436,31,1.40 [0.48-4.08],0.5372159397887204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,19671,31,0.64 [0.17-2.44],0.5132909638546217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,19667,31,0.95 [0.27-3.39],0.9398966195211692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,19637,31,0.96 [0.58-1.60],0.8871391011128329
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,19169,30,0.86 [0.61-1.23],0.4135943784988561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,19070,31,1.03 [0.67-1.60],0.8864411244792145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,22025,31,0.88 [0.50-1.53],0.6449976090412446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,18973,28,1.25 [0.49-3.22],0.6394347141812373
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,19567,30,0.72 [0.47-1.11],0.1381381375628971
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,22075,32,1.03 [0.61-1.75],0.9025502624078005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,22656,33,1.03 [0.67-1.60],0.8929836563323001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19070,31,0.57 [0.22-1.50],0.2526329382084777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19070,31,0.93 [0.30-2.82],0.892398194739223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19070,31,1.16 [0.55-2.45],0.6912493066239676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,18973,28,0.59 [0.22-1.63],0.3138492639400345
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,19070,31,0.57 [0.25-1.29],0.175944380634302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",19070,31,1.15 [0.67-1.96],0.621628482361273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",22689,32,0.76 [0.58-1.00],0.0498964177196884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",22025,31,0.46 [0.21-1.03],0.060118518091912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,22075,32,1.08 [0.53-2.22],0.8252410327686979
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,22482,31,0.41 [0.11-1.52],0.1833045087238562
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,21977,31,0.66 [0.39-1.11],0.1203176699679529
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,19169,30,0.86 [0.52-1.41],0.5446232426236419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,19070,31,0.75 [0.52-1.07],0.1165921138116886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,19567,30,1.25 [0.52-2.97],0.6192649179911107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",19696,31,1.01 [0.13-8.01],0.992221171849453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,22025,31,0.94 [0.61-1.46],0.7916400673746684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,19061,30,0.84 [0.57-1.22],0.3480837720124883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,19637,31,1.09 [0.54-2.19],0.8047970600326885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,19628,31,1.27 [0.75-2.15],0.3810618478447899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,22547,32,0.81 [0.58-1.14],0.2219818004261026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,22650,34,2.21 [0.78-6.26],0.1339805990762855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,19637,31,1.33 [0.75-2.36],0.3342908268533301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,21867,31,0.97 [0.64-1.47],0.8867897101150699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,19696,31,1.49 [0.87-2.55],0.1426886310883451
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19070,31,1.26 [0.26-6.06],0.7706906901736222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19169,30,1.23 [0.47-3.24],0.6762467093848612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",22689,32,5.35 [2.04-14.02],0.0006419069821892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",22595,33,1.03 [0.29-3.73],0.963011089714552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,19118,29,1.16 [0.39-3.46],0.7909837781841951
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,22547,32,1.01 [0.65-1.57],0.9528634310140888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,22401,31,0.72 [0.36-1.44],0.3512801344956227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,19118,29,1.50 [0.81-2.77],0.1933582849434597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,22185,33,1.33 [0.57-3.11],0.5040621638391933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22075,32,1.15 [0.71-1.86],0.5770763769170718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,22075,32,1.63 [0.63-4.27],0.3157238808161779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,22547,32,1.03 [0.76-1.39],0.8720069168600662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,19628,31,1.76 [1.39-2.23],2.9565292949920977e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,19121,30,1.22 [0.91-1.64],0.1778722581976825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,21995,31,0.78 [0.54-1.14],0.1950533183353209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,22595,33,2.61 [0.79-8.67],0.1162824080862796
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,22436,31,1.16 [0.45-2.97],0.761601928757812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19667,31,1.50 [0.56-4.01],0.4215378845112055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19061,30,1.18 [0.69-2.04],0.540850907402096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,19298,30,1.95 [0.54-7.10],0.3104534965637381
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,19567,30,2.00 [1.53-2.62],4.291757160329354e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,19628,31,0.82 [0.58-1.16],0.2676150309089382
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22547,32,1.52 [0.70-3.27],0.289094667897421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,19118,29,0.58 [0.27-1.25],0.1645605262595668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,18973,28,0.52 [0.26-1.03],0.0623960667007113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,19561,30,1.50 [0.88-2.56],0.1319497929422893
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,22547,32,0.97 [0.68-1.38],0.8718154888681782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,19662,30,0.68 [0.46-1.00],0.0495451664275772
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,19169,30,1.04 [0.59-1.85],0.892739422397838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,18973,28,0.68 [0.27-1.73],0.4196887394399736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,19662,30,0.92 [0.63-1.33],0.6410016412785033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,22036,32,1.24 [0.97-1.60],0.0850900475096758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,19061,30,1.41 [1.00-1.98],0.0489992406441396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19070,31,1.18 [0.31-4.47],0.8079209916571722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,22547,32,0.81 [0.50-1.32],0.4021177311297369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,22595,33,0.85 [0.60-1.20],0.3519804085915317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,22075,32,0.77 [0.46-1.30],0.3336018442777412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,22858,34,0.65 [0.30-1.41],0.2759195373307048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,19118,29,3.32 [2.57-4.30],7.533247538952965e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19061,30,0.67 [0.37-1.23],0.1939105427259012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19628,31,0.96 [0.40-2.29],0.9318210652404048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,22595,33,1.21 [0.79-1.84],0.3804388605799048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,19255,29,0.83 [0.24-2.91],0.7771674255347724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,22401,31,0.89 [0.43-1.82],0.7456446071138736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,22149,33,0.83 [0.41-1.68],0.6035655541320952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,19255,29,9.64 [3.66-25.40],4.561777174062205e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19667,31,1.37 [0.54-3.46],0.5048573492890693
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19118,29,2.50 [1.47-4.26],0.0006985809455938
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,22185,33,0.97 [0.26-3.64],0.96074125551683
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,19061,30,1.03 [0.55-1.93],0.9240360101441164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,19169,30,1.17 [0.62-2.19],0.6314171107357494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,18487,28,1.12 [0.81-1.55],0.5020100141633834
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,22528,32,0.59 [0.38-0.92],0.0189216014217924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,19633,31,0.90 [0.54-1.51],0.6890096170298479
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,19397,30,0.88 [0.64-1.22],0.4454737432292364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,19289,30,0.82 [0.24-2.74],0.7420587435848476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,19061,30,2.03 [1.34-3.08],0.000854626865877
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,19070,31,0.95 [0.45-2.00],0.9011557897117808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,19070,31,1.23 [0.50-3.01],0.6531643565339655
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,22025,31,0.82 [0.39-1.72],0.6039598782316252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,19061,30,1.07 [0.51-2.24],0.8501324458359153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,19637,31,0.88 [0.36-2.12],0.7736987805252715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BSG,Basigin,22795,33,3.82 [0.89-16.44],0.0717243314903145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BSND,Barttin,18973,28,0.58 [0.16-2.06],0.4001126746038197
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22785,32,0.71 [0.44-1.14],0.1583216285117061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,22785,32,1.03 [0.57-1.85],0.9218634958128948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,22075,32,0.64 [0.39-1.04],0.0727441048563432
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,19696,31,0.57 [0.12-2.68],0.4775829175306764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,18973,28,0.65 [0.35-1.20],0.1691704604457575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,19526,30,0.88 [0.35-2.22],0.7842954411226251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,22689,32,2.71 [0.95-7.67],0.0611721716406517
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,22547,32,1.35 [0.60-3.06],0.4670311541189539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,18973,28,0.37 [0.10-1.36],0.1362845292298403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,22025,31,1.20 [0.78-1.85],0.4036612596469614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,19070,31,0.41 [0.12-1.35],0.1416823448367731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,22718,33,4.14 [1.18-14.50],0.0261997444631842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19637,31,1.06 [0.69-1.64],0.775330137912537
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,19118,29,1.19 [0.55-2.56],0.6623741060456859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22650,34,0.95 [0.47-1.93],0.8847626392707058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19255,29,0.73 [0.30-1.73],0.4688685530395853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19637,31,1.91 [0.93-3.96],0.0801264695169235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19213,29,1.17 [0.54-2.51],0.6887069102386245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,19696,31,0.39 [0.04-3.39],0.392163130270043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,19664,31,1.51 [0.25-9.01],0.6539901383456381
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,19696,31,0.51 [0.11-2.42],0.3973108273809627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2,Complement C2,22613,34,0.56 [0.36-0.85],0.0073589801514702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,21977,31,0.53 [0.24-1.17],0.1144091849514441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,19121,30,0.87 [0.45-1.70],0.687441925921598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C3,Complement C3,18689,27,0.99 [0.44-2.24],0.9773017121451184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,22656,33,0.84 [0.39-1.79],0.6522986919016704
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C5,Complement C5,19696,31,1.14 [0.13-10.42],0.9046744017618308
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,19221,31,2.15 [0.70-6.67],0.183222782659582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,19628,31,2.78 [1.93-4.01],4.6652646966136686e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,19696,31,0.75 [0.44-1.28],0.297396884532582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,19671,31,2.29 [1.08-4.86],0.0301500716115998
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,19567,30,1.30 [0.88-1.93],0.1824513476424052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,22056,34,1.23 [0.77-1.97],0.3856691753627455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,22075,32,1.02 [0.40-2.62],0.9680133730595768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,22482,31,1.73 [0.72-4.17],0.2214866058888495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,22349,33,0.89 [0.67-1.19],0.4356129440906117
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,22787,33,1.39 [0.57-3.39],0.4643403674767062
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,22518,32,1.06 [0.69-1.63],0.7748920235671802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,22819,34,1.33 [0.85-2.10],0.2133239304842487
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,22858,34,1.29 [0.35-4.68],0.7011329959998274
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",22185,33,1.13 [0.82-1.56],0.4410583229456797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,22523,33,0.67 [0.41-1.09],0.1087553123718231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,19289,30,0.73 [0.24-2.20],0.5747647422848428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,19118,29,0.92 [0.23-3.66],0.9090131095440686
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,22787,33,1.10 [0.57-2.11],0.7739753699293235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,19121,30,1.04 [0.62-1.75],0.8759287785670087
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19061,30,1.74 [0.86-3.51],0.1239020654051954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19070,31,1.15 [0.71-1.84],0.5690709209102613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19061,30,1.52 [0.98-2.35],0.0632193627673314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19637,31,0.87 [0.58-1.31],0.511071266983572
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,19212,29,0.77 [0.55-1.09],0.135906868479768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,19121,30,0.72 [0.27-1.92],0.5146154734133261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,22482,31,1.67 [0.77-3.62],0.1940247661979292
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,22025,31,0.58 [0.19-1.77],0.3380431025474808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,22388,31,1.22 [0.72-2.07],0.4517463375673762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,19628,31,1.02 [0.43-2.39],0.9671455898490688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22714,33,0.93 [0.69-1.26],0.6371637235147225
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19169,30,1.17 [0.75-1.82],0.4860393110633165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,19070,31,1.14 [0.51-2.53],0.7473029996984986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22075,32,1.29 [0.66-2.52],0.4542396518927096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19121,30,0.91 [0.46-1.78],0.7847476967640152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19637,31,0.96 [0.70-1.33],0.825464047473768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,22522,34,8.74 [2.07-36.87],0.0031586496053005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,22431,30,1.40 [0.83-2.36],0.2047905884409062
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,19561,30,0.58 [0.18-1.84],0.3537567707922925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,19628,31,0.95 [0.65-1.40],0.7952404212377272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,22025,31,0.83 [0.45-1.55],0.5694099468907221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,19121,30,1.69 [0.80-3.54],0.1663662277173003
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,22025,31,0.87 [0.53-1.41],0.5664817710935698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,22025,31,0.72 [0.48-1.07],0.1059571600135953
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,22547,32,0.75 [0.47-1.22],0.2539200914235694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,22858,34,0.87 [0.62-1.23],0.4356270328468313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,19289,30,0.83 [0.64-1.07],0.1452787025997767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,19628,31,0.94 [0.62-1.42],0.7731295105484749
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,22715,33,0.88 [0.53-1.47],0.6295373604476198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,19118,29,1.12 [0.65-1.93],0.69013789948837
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,19070,31,0.36 [0.12-1.06],0.0645089338470651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAT,Catalase,19368,30,1.06 [0.57-1.97],0.8488105397000143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,22554,34,1.11 [0.74-1.67],0.6195028191533374
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,19061,30,0.92 [0.62-1.37],0.6956656982877512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,22787,33,0.49 [0.19-1.30],0.1535271456358015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,19169,30,1.14 [0.60-2.18],0.6932230432966275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,19070,31,0.54 [0.16-1.81],0.3212413357804022
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22436,31,0.87 [0.56-1.36],0.5332925449780932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,19628,31,1.39 [0.96-2.01],0.0816224273799938
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,19561,30,0.72 [0.34-1.54],0.4025403341045045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,19121,30,1.64 [0.50-5.36],0.4146453402427599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,19637,31,1.39 [1.03-1.88],0.0293248737680498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,22588,34,1.76 [0.79-3.90],0.1662413412295008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19169,30,0.95 [0.53-1.69],0.8576445889499975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,22835,33,0.68 [0.30-1.55],0.3555017987092538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,22795,33,0.82 [0.52-1.29],0.3862255458219175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,22505,34,0.76 [0.34-1.71],0.5092213066437963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,22858,34,1.06 [0.53-2.12],0.8671436515403631
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,22858,34,0.89 [0.51-1.54],0.6656223278197639
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,22554,32,0.87 [0.61-1.23],0.434750102782579
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,22241,34,1.12 [0.75-1.67],0.5957335257244545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,22785,32,0.89 [0.68-1.17],0.4010588757136304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,22401,31,1.38 [0.78-2.43],0.2652626721959647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,22835,33,1.00 [0.71-1.40],0.978514679597443
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,22689,32,1.08 [0.55-2.14],0.8169713813740824
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,22363,32,1.04 [0.56-1.92],0.8963748084691627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,22689,32,0.63 [0.29-1.36],0.239465478931127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,22650,32,0.95 [0.65-1.38],0.7715131188113477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,22835,33,1.01 [0.53-1.91],0.9832541242121656
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,22547,32,0.83 [0.56-1.22],0.3449164617583601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,22588,34,1.11 [0.66-1.86],0.6924940255508896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,22472,32,0.78 [0.44-1.37],0.3865382431477157
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,22547,32,1.52 [1.20-1.93],0.0006209771569564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,22621,32,1.34 [0.99-1.80],0.0582805285405762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,22650,34,0.78 [0.58-1.05],0.1055418555444313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,22547,32,1.12 [0.69-1.82],0.6536899441636774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,22754,33,0.84 [0.51-1.37],0.483051335932657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,22442,31,0.77 [0.52-1.15],0.2022649004845407
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,22576,31,0.51 [0.29-0.91],0.0228961386682912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,22825,34,2.22 [1.04-4.72],0.0381255656166499
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,22787,33,0.77 [0.35-1.68],0.5112511440914836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,22595,33,1.39 [0.64-3.00],0.4019821628992931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,19289,30,1.32 [0.50-3.45],0.5778751829586309
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,19118,29,1.25 [0.97-1.60],0.0796350982468534
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,22436,31,1.19 [0.62-2.26],0.6005312231581597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,22075,32,1.20 [0.63-2.29],0.5786527389634908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,19567,30,0.92 [0.40-2.08],0.8357722973259227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,22595,33,1.19 [0.47-3.03],0.7180826035791508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,22088,34,1.17 [0.56-2.46],0.670681872181403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,22835,33,1.00 [0.51-1.96],0.9926531554308872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,22650,34,1.96 [1.03-3.75],0.0411094566202959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,22595,33,1.42 [0.56-3.59],0.4597633706812349
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,19121,30,0.96 [0.37-2.50],0.9270668749454908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,22566,33,1.60 [1.20-2.13],0.0014479089436603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,22656,33,6.76 [1.99-23.01],0.0022204701017699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,19070,31,0.88 [0.34-2.32],0.8014372941617967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,22547,32,2.09 [1.38-3.17],0.0004882913404933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,22479,32,1.18 [0.48-2.89],0.721117372071205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,22089,30,0.91 [0.39-2.15],0.8331462391712495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,22633,32,0.97 [0.44-2.15],0.9421129733296112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,22835,33,6.99 [4.84-10.10],4.165702847374711e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,19118,29,0.49 [0.20-1.18],0.1094712528235073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,22835,33,1.11 [0.35-3.51],0.8553683541817458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,19662,30,1.34 [0.56-3.18],0.5094259103064833
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,22656,33,5.48 [3.47-8.66],3.133366111370168e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,22436,31,1.48 [0.64-3.44],0.3588097360891029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,22580,32,1.55 [0.64-3.76],0.3351196215010817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,22075,32,2.08 [1.28-3.39],0.0032667938821239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,22588,34,1.37 [0.87-2.15],0.1738062913054385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,19255,29,3.19 [1.03-9.91],0.0445077698542855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,22785,32,1.23 [0.50-3.02],0.6517138504199647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,22707,32,2.23 [1.13-4.42],0.0211997177103037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,22787,33,1.56 [0.87-2.77],0.1327586618531362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,22595,33,1.01 [0.44-2.32],0.9781105988994104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,22482,31,1.82 [0.67-4.95],0.237636873859054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,22656,33,0.81 [0.56-1.16],0.2452269761307391
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,22703,32,2.94 [0.82-10.52],0.09661042175739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,19118,29,0.65 [0.28-1.51],0.3152700438045487
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22482,31,1.48 [0.53-4.14],0.4500679883764322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,19061,30,1.61 [0.90-2.89],0.109394552754976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,19289,30,1.11 [0.47-2.65],0.8151528179372536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,19118,29,1.14 [0.84-1.55],0.4080947235661906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,22505,32,1.88 [0.95-3.71],0.0701408089002695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,22582,32,0.69 [0.35-1.35],0.2759618431160942
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,22835,33,0.83 [0.56-1.24],0.3640363263677414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,22424,34,2.60 [1.17-5.79],0.0193168710912281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,22650,32,22.95 [10.88-48.40],1.902610339532773e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,22754,33,19.73 [12.28-31.69],6.546291554845958e-35
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,21778,33,1.97 [0.85-4.56],0.1112114045327752
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,22546,32,1.50 [0.25-9.02],0.6549412643097752
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,21750,31,3.33 [1.30-8.50],0.0120528126905174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,19578,30,0.94 [0.44-2.00],0.8650141025879649
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,22795,33,3.56 [2.04-6.20],7.303533379673845e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,22401,31,0.63 [0.35-1.14],0.1291908427769946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,22491,34,0.93 [0.66-1.32],0.6982088040636606
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,19079,29,1.85 [1.00-3.42],0.0490756752483719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,22547,32,6.95 [4.62-10.47],1.4107101939941062e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,19255,29,9.01 [5.98-13.56],5.907004521367555e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,22785,32,8.21 [4.58-14.71],1.450489815727904e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,22835,33,6.76 [5.01-9.13],1.0330344384875862e-35
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,19667,31,12.84 [7.80-21.14],1.0758634951446173e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,19289,30,0.88 [0.36-2.17],0.786183760218989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,22547,32,8.20 [4.28-15.71],2.1639664307703683e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,22547,32,0.57 [0.21-1.57],0.2802309518114677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,19567,30,6.87 [2.90-16.27],1.1687741676797862e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,22785,32,1.48 [0.81-2.71],0.2030242725282149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,21702,32,1.39 [0.51-3.74],0.5186356968486261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,22595,33,1.05 [0.21-5.29],0.9491746611195698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,22595,33,0.60 [0.16-2.27],0.4499332267837803
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,19625,30,0.97 [0.46-2.02],0.93095729498183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,19628,31,0.92 [0.21-4.08],0.9149338620195858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,18973,28,0.84 [0.44-1.58],0.5814634476166209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,18973,28,0.34 [0.12-0.98],0.0460436311424188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,19539,30,0.89 [0.53-1.48],0.6416559438710062
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,22075,32,1.38 [0.88-2.18],0.1587342589812895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,22656,33,0.85 [0.59-1.23],0.3924991855561424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,19567,30,0.80 [0.56-1.14],0.2104899739619849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,22436,31,2.08 [1.22-3.55],0.0074650739682843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,21803,33,0.73 [0.30-1.76],0.4801056173319032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,22737,32,0.48 [0.21-1.09],0.0801678823911292
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,22588,34,0.78 [0.49-1.25],0.2965540990646931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,22588,34,1.59 [0.68-3.73],0.2867155723600705
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,19289,30,0.94 [0.27-3.22],0.9198239310178328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,19628,31,0.72 [0.19-2.77],0.631591923609431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,22785,32,1.66 [0.74-3.74],0.2231398324106318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,19061,30,0.79 [0.35-1.79],0.5723018966805138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,22858,34,2.36 [0.97-5.78],0.0595792361525364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,22588,34,1.83 [0.84-3.99],0.1299391870928854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,22025,31,0.57 [0.24-1.37],0.2090659185605303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,22482,31,1.02 [0.67-1.56],0.9081355146212012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,22588,34,1.18 [0.53-2.62],0.6798577840460884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,18973,28,0.83 [0.31-2.25],0.7208877495306699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19637,31,0.68 [0.35-1.32],0.2543716044336783
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,19061,30,1.09 [0.61-1.97],0.7668885828711485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,22482,31,0.80 [0.59-1.08],0.1471655781355159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22482,31,0.75 [0.55-1.03],0.0728292994999018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,22482,31,0.59 [0.21-1.65],0.3177116508007597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22622,32,0.42 [0.13-1.33],0.1410970198062853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,22754,32,0.91 [0.44-1.87],0.7956058486709234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22618,33,0.63 [0.19-2.06],0.4469730323068615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19567,30,1.07 [0.68-1.69],0.7720372121884672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19289,30,0.49 [0.21-1.14],0.0985610981551366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19567,30,0.60 [0.25-1.45],0.2584902046867829
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19289,30,0.75 [0.31-1.81],0.5215755672545661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22547,32,2.00 [1.44-2.78],3.557739358759844e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22075,32,0.47 [0.23-0.99],0.0482545728061051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21773,32,0.97 [0.59-1.60],0.897361338691659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19662,30,0.77 [0.28-2.10],0.6107242226370738
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22185,33,1.01 [0.54-1.89],0.9628848687700562
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,19118,29,1.01 [0.40-2.51],0.9887930840942264
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,22185,33,0.38 [0.15-0.95],0.0377990436651083
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,19662,30,1.36 [0.75-2.49],0.3150632362725782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,22820,34,0.99 [0.58-1.70],0.9763332378960164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19255,29,0.62 [0.17-2.25],0.4712076390849129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,19118,29,1.57 [0.88-2.79],0.1234518834426465
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,19061,30,0.89 [0.46-1.73],0.740034637715451
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,19289,30,0.93 [0.49-1.78],0.8330322027741692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,19289,30,0.96 [0.58-1.60],0.8801083624611118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,19070,31,0.32 [0.09-1.14],0.0796762185579278
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,18973,28,0.67 [0.25-1.80],0.4321112844607748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,22160,32,0.92 [0.53-1.59],0.7604753464992728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,19169,30,0.88 [0.55-1.42],0.5967198868178505
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,22075,32,0.65 [0.41-1.03],0.0688631204993764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,19289,30,0.75 [0.34-1.63],0.4672542772825322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,18973,28,0.71 [0.26-1.99],0.5173612560763026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,22009,33,1.19 [0.77-1.86],0.4324285525689462
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,22075,32,1.07 [0.65-1.74],0.800804708771389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,22025,31,0.80 [0.47-1.36],0.4086914225474849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,22633,34,0.92 [0.62-1.36],0.6667139119459915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,22482,31,0.73 [0.39-1.36],0.3149746875982694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,22482,31,0.64 [0.37-1.10],0.1075314970006661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,22025,31,0.93 [0.57-1.51],0.7698904564262986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,19567,30,0.77 [0.48-1.24],0.2868217447539196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,19319,29,1.11 [0.37-3.29],0.8575378356009751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,22075,32,1.43 [0.83-2.45],0.1930028506752956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,19696,31,0.62 [0.10-3.80],0.604350309965199
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,18530,28,0.83 [0.17-4.02],0.8215941706247908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,19554,31,0.73 [0.43-1.24],0.2508308091497611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,19665,31,0.98 [0.61-1.56],0.9255460381545207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,19404,30,0.62 [0.34-1.15],0.1303291527492967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,19696,31,1.02 [0.18-5.62],0.9852905867825688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFP,Properdin,19696,31,2.04 [1.12-3.71],0.0196775860709096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,22595,33,0.80 [0.55-1.17],0.2528322623635325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19671,31,0.90 [0.38-2.12],0.8084004282148072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,19121,30,1.14 [0.54-2.41],0.7275670308873425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,22588,34,1.87 [0.94-3.70],0.0733180000564197
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22075,32,0.98 [0.59-1.65],0.951368517068208
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,19255,29,0.79 [0.41-1.52],0.4847534912917794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19628,31,3.41 [2.20-5.26],3.320039118401767e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,19561,30,1.25 [0.43-3.65],0.6803498693898946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,22185,33,0.72 [0.28-1.85],0.4963717250956141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,19662,30,1.19 [0.84-1.66],0.3266536756089695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,22694,32,1.67 [0.78-3.58],0.1847241943761456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,22062,34,1.18 [0.80-1.73],0.405618710491881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,22679,34,0.97 [0.80-1.16],0.7153705269261691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,22613,34,0.38 [0.13-1.08],0.0704381319410093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,19121,30,0.78 [0.43-1.43],0.4187630590395443
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,22436,31,0.65 [0.44-0.96],0.0320314500671171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,19667,31,0.68 [0.36-1.27],0.2214159891315924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,19061,30,0.68 [0.39-1.21],0.1931157481000072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,22650,32,1.73 [0.62-4.81],0.2960682823146207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,22588,34,1.36 [0.80-2.32],0.2536517562044548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,19121,30,0.90 [0.34-2.42],0.841759430595503
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,22656,33,0.73 [0.45-1.19],0.2012648727325726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,19662,30,0.82 [0.44-1.51],0.5139861824190016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,19289,30,0.96 [0.43-2.15],0.919756580797437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,19567,30,0.80 [0.55-1.15],0.2240758571324356
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,19121,30,1.45 [0.77-2.70],0.2464687236972262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,22727,33,3.92 [2.11-7.31],1.6189688352334558e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,19662,30,1.76 [0.99-3.13],0.0542388542558025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22506,32,0.89 [0.61-1.32],0.5700450761125717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,18973,28,0.85 [0.49-1.49],0.5787566068777302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,22553,34,0.65 [0.38-1.09],0.1010001732729976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,22436,31,0.90 [0.37-2.17],0.8147751861971886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,22547,33,0.96 [0.50-1.82],0.8958838326428996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,19118,29,4.09 [2.04-8.16],6.735573709627647e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,22595,33,2.75 [1.15-6.58],0.0229086107583799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,22185,33,1.58 [0.63-3.97],0.3292749064758255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,22785,32,0.81 [0.58-1.12],0.205620326062265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,19121,30,0.49 [0.17-1.37],0.175122971981048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,19221,29,0.99 [0.18-5.31],0.986658971588327
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,22547,32,1.21 [0.48-3.07],0.6843413799664884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,22547,32,1.36 [0.71-2.62],0.3537992640581605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,22547,32,1.08 [0.65-1.79],0.7683083916320181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,22547,32,1.61 [0.63-4.08],0.3173905901232737
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,19623,30,0.85 [0.42-1.75],0.6659973035347705
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,22521,34,2.09 [0.78-5.59],0.1411486717760968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,22075,32,1.20 [0.62-2.30],0.5863504902665497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,22835,33,1.22 [0.66-2.26],0.5216764258763775
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,19121,30,0.80 [0.35-1.86],0.6088479070019436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,19121,30,0.49 [0.13-1.86],0.2905833836384167
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,18973,28,0.88 [0.36-2.11],0.7672521507703087
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,22547,32,0.87 [0.66-1.14],0.3088699501685918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,22787,33,2.47 [0.56-10.88],0.2305548787524558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,19121,30,1.34 [0.51-3.54],0.5552578673471005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22388,31,0.89 [0.63-1.25],0.5030172132961697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,22560,33,0.97 [0.62-1.52],0.888970431640383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,21977,31,0.56 [0.17-1.83],0.3377443577769128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,22025,31,0.87 [0.45-1.67],0.6759360796447511
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,22835,33,1.05 [0.48-2.28],0.9036527946557708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,19628,31,4.09 [2.42-6.91],1.3125578594664644e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,22185,33,0.84 [0.42-1.67],0.6104687726538971
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,19696,31,0.72 [0.16-3.18],0.664117360505187
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,22557,34,1.11 [0.57-2.15],0.7625143773132245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,19667,31,0.80 [0.54-1.18],0.2622383580773366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,19561,30,0.67 [0.43-1.05],0.0783197677853611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,22650,34,0.61 [0.34-1.08],0.0910118916966039
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,19061,30,0.49 [0.19-1.27],0.1409710122018378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19132,30,0.83 [0.53-1.30],0.4147760143107067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,22185,33,0.75 [0.40-1.41],0.3737488439473311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,22482,31,0.65 [0.43-1.00],0.0502892186571578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNST,Consortin,22588,34,0.97 [0.73-1.28],0.8147261852403089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,19061,30,0.96 [0.34-2.68],0.9366035466962894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,22858,34,1.78 [0.59-5.38],0.3080393845825386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,22787,33,1.11 [0.56-2.18],0.7651493892951149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,22595,33,0.70 [0.29-1.67],0.4236266049390415
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,22595,33,0.83 [0.23-3.02],0.780657899602688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,22637,32,1.53 [0.67-3.48],0.3112116814397215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,22547,32,2.27 [1.13-4.54],0.0206208748811205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,19121,30,0.84 [0.55-1.29],0.4357881096577352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,19667,31,2.54 [1.39-4.65],0.0024045188034981
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,19662,30,0.97 [0.25-3.75],0.9681197752032152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,22682,34,1.63 [0.44-6.02],0.4672391360860451
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,22858,34,0.50 [0.16-1.57],0.2358846695736677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,19567,30,0.68 [0.41-1.15],0.1488540026232429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,19121,30,1.27 [0.81-1.99],0.2991256170388204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,19169,30,0.72 [0.46-1.14],0.1644297423858206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,19662,30,1.73 [0.41-7.21],0.4526198750543512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,22588,34,2.19 [1.10-4.40],0.0265536693694914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,19258,30,0.95 [0.50-1.82],0.8874221691710997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,19255,29,1.23 [0.51-2.97],0.6492734761149854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,22858,34,1.54 [0.66-3.61],0.3211657060753705
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,22547,32,0.79 [0.41-1.55],0.4972763888088436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,19289,30,1.15 [0.61-2.17],0.6699324523480976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,22580,32,2.76 [0.89-8.63],0.079983745827934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,19169,30,0.89 [0.50-1.60],0.7020727724727567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,19561,30,1.56 [0.83-2.92],0.1666856573766179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,22323,34,1.91 [0.76-4.78],0.1654217978035312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,21950,33,0.93 [0.64-1.35],0.7095300842859447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',19070,31,1.22 [0.56-2.66],0.6178280573941325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,22025,31,0.30 [0.12-0.78],0.0139494480671588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19169,30,0.90 [0.39-2.05],0.7958257080184045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,22102,32,0.94 [0.66-1.35],0.747440282849545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,19061,30,0.84 [0.30-2.34],0.7374397137373507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22482,31,0.77 [0.48-1.25],0.2965384256080506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,19667,31,1.37 [0.50-3.76],0.5373666976222966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,22858,34,0.91 [0.54-1.53],0.7153084832835785
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,22699,32,0.68 [0.41-1.14],0.1435535404175262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,18864,28,1.07 [0.46-2.50],0.8779324193907406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,22858,34,0.94 [0.55-1.60],0.8167988757059279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,19652,31,0.77 [0.38-1.59],0.4847604911055913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,22624,32,2.13 [0.80-5.69],0.1314136470759125
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,18973,28,0.85 [0.25-2.92],0.7926980998981362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,22678,32,1.32 [0.54-3.20],0.5436074750052424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19118,29,1.90 [0.71-5.06],0.1985289364784354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,22785,32,0.91 [0.57-1.46],0.7078362586364919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,19620,30,0.74 [0.31-1.74],0.4898578199294274
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,19070,31,0.62 [0.22-1.72],0.3585001660086737
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,22759,33,3.64 [1.69-7.84],0.0009857664702148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,22656,33,0.78 [0.50-1.22],0.2742150295481779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,19667,31,1.32 [0.38-4.55],0.6638138729327456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,19589,30,3.44 [1.40-8.45],0.0070890888622304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,22650,34,1.68 [0.88-3.20],0.1136824255586772
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22075,32,0.93 [0.64-1.35],0.6961812510084906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,22388,31,0.88 [0.58-1.34],0.5539093256993894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,18973,28,0.54 [0.24-1.24],0.1488217344106601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,18973,28,1.10 [0.28-4.35],0.8871655531532493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,22289,33,1.47 [0.65-3.35],0.3537178139061879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,19255,29,1.14 [0.44-2.93],0.7927622716110689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,22650,32,0.69 [0.37-1.28],0.2446963537663682
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,22033,31,2.08 [1.53-2.82],2.449015169594693e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,22580,32,3.45 [1.13-10.54],0.0295082137332244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,22185,33,0.87 [0.51-1.49],0.6031200183125713
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,22689,32,1.97 [0.44-8.86],0.3756896390365318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,22436,31,1.18 [0.51-2.72],0.7007499323973648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,22787,33,0.94 [0.58-1.54],0.8123794129030999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,19491,31,1.73 [0.48-6.19],0.3983315865045185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,22616,32,0.75 [0.57-1.01],0.0553924458308027
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,22689,32,2.74 [0.79-9.51],0.1113781367189478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,21943,30,1.01 [0.62-1.65],0.966306612279002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,22858,34,0.94 [0.34-2.62],0.9058131726508656
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,22436,31,3.81 [2.21-6.57],1.394384683049276e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,19121,30,0.78 [0.34-1.79],0.5623399815740557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,22185,33,0.88 [0.63-1.24],0.4766882437497782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,19667,31,0.82 [0.48-1.42],0.4786604190107009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,19628,31,0.61 [0.27-1.40],0.2431966203475085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,19628,31,0.86 [0.60-1.22],0.4015468553435882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,19061,30,0.88 [0.53-1.46],0.6168390390780043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,19169,30,0.91 [0.62-1.34],0.6357618286721989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,19070,31,0.84 [0.59-1.18],0.3120664588039548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,22689,32,4.29 [1.71-10.76],0.0018811189976556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,19671,31,3.90 [2.17-6.99],5.049354937914064e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,19070,31,1.53 [0.67-3.52],0.3110352171796178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22436,31,1.34 [0.86-2.10],0.199148519743305
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,19118,29,2.09 [0.94-4.64],0.0687526628609739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,22160,32,0.59 [0.30-1.16],0.123481681308203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,19118,29,1.74 [0.72-4.24],0.2219307005346142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,19671,31,1.43 [0.92-2.23],0.115276573805433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,19118,29,1.35 [0.84-2.15],0.2106376306838673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,19637,31,1.61 [0.79-3.31],0.1922485444272668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,19662,30,1.25 [0.43-3.66],0.684596060583445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,19061,30,1.38 [0.79-2.39],0.2541777303979342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,19070,31,1.13 [0.82-1.56],0.4527679668179728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,17062,25,1.14 [0.78-1.67],0.4861406103252462
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,22617,34,1.01 [0.34-3.07],0.979314376711641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,22205,31,0.88 [0.49-1.57],0.6689721475107282
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,22013,33,0.79 [0.41-1.51],0.4718864381999994
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,22621,32,0.94 [0.66-1.34],0.7455400721419277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,22275,33,2.71 [1.54-4.78],0.0005748880119105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,19246,30,1.36 [0.77-2.41],0.2933731805599233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,19375,29,1.87 [0.48-7.27],0.3641795599466777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,22185,33,0.72 [0.49-1.06],0.0978559997947971
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,19662,30,2.98 [1.14-7.82],0.0263049449398015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,19662,30,1.69 [0.78-3.65],0.1808922810524794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,19061,30,1.01 [0.39-2.61],0.9888336431499094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,22595,33,1.14 [0.65-2.00],0.6489228854773184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,22589,32,1.35 [0.83-2.21],0.2247068241661919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,19628,31,1.54 [0.92-2.57],0.1013001052834273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,22605,33,2.37 [1.48-3.78],0.0003008029782372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,22544,31,1.26 [0.62-2.58],0.5238374239400354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,21066,32,1.90 [1.08-3.33],0.0257262080724156
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,19255,29,1.87 [0.95-3.68],0.0682233888276144
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,22656,33,0.71 [0.32-1.54],0.3820016686801369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,22122,32,1.36 [0.89-2.08],0.1563393223100245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,22588,34,9.12 [3.59-23.16],3.309751313641912e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,22835,33,1.65 [0.62-4.36],0.3139971132296673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,17736,26,4.49 [1.16-17.40],0.0297900207715293
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,22728,33,0.44 [0.21-0.95],0.0354473316396781
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,22571,34,2.07 [0.80-5.32],0.1316348140753764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,19121,30,2.17 [1.54-3.07],1.1243502173570612e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,19449,30,1.66 [1.20-2.30],0.0024511411077001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,22436,31,0.82 [0.32-2.14],0.6919904466977601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,22547,32,1.14 [0.65-2.01],0.6475223081012722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,22545,31,0.81 [0.57-1.15],0.2317032877491999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,22689,32,1.04 [0.66-1.63],0.8769446921865705
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,22785,32,1.08 [0.74-1.58],0.6709230211980647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,22160,32,1.07 [0.50-2.32],0.8567904111741064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,22785,32,1.51 [1.15-1.98],0.0032204818977307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,22160,32,1.27 [0.90-1.80],0.1722055636916174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,22819,34,0.68 [0.18-2.48],0.5556435281128488
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,22835,33,1.25 [0.58-2.69],0.5701911722198961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,22582,32,0.62 [0.46-0.84],0.0018231215303899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,22515,34,0.73 [0.56-0.94],0.0147365846567558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,22835,33,1.04 [0.70-1.54],0.8505994153313494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,22412,33,0.83 [0.51-1.35],0.4632394872189155
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,22689,32,1.46 [1.00-2.14],0.049922578673975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,18973,28,0.60 [0.32-1.14],0.1214206855987938
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,19324,29,1.89 [1.16-3.09],0.0107870954092854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19070,31,1.06 [0.73-1.53],0.7653387783170599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,18973,28,0.53 [0.28-1.02],0.0555637182834736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,19662,30,2.20 [0.50-9.64],0.2975502762322428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,19255,29,0.74 [0.48-1.16],0.193956313352484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,22787,33,0.84 [0.64-1.11],0.2179633311557417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,22689,32,0.56 [0.28-1.12],0.1025755164779999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,19118,29,0.65 [0.34-1.24],0.1923643879025601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,19118,29,0.86 [0.43-1.73],0.6798437875605094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22547,32,0.83 [0.66-1.05],0.1206035309455276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",22388,31,0.79 [0.51-1.22],0.2947974934267959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,19629,30,1.18 [0.81-1.74],0.3851238759749947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,22496,33,1.02 [0.68-1.51],0.931043220301836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,19118,29,1.07 [0.54-2.12],0.8566439297232872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,22689,32,0.76 [0.54-1.06],0.1067522723951053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22656,33,1.39 [0.58-3.34],0.463654400746042
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,19121,30,0.83 [0.16-4.27],0.8221113194708252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,18973,28,1.07 [0.64-1.79],0.8011556177692801
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,18973,28,0.33 [0.09-1.15],0.0815272813421133
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCN,Decorin,22185,33,2.31 [0.64-8.32],0.201758180475835
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,19255,29,0.73 [0.50-1.06],0.0953161701771108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,22787,33,0.79 [0.49-1.27],0.3308195272218999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,22482,31,1.04 [0.75-1.45],0.8104677658049619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,22025,31,0.68 [0.40-1.15],0.1499998894636052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,22588,34,4.04 [1.74-9.43],0.00120987089779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,19061,30,1.09 [0.72-1.66],0.6749242745904884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,18973,28,0.84 [0.51-1.38],0.4854701231202408
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,22656,33,1.18 [0.67-2.09],0.5628224895643841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,19070,31,0.99 [0.43-2.31],0.9856376053462692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22482,31,1.27 [0.64-2.50],0.494514877251593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,22554,34,1.19 [0.64-2.21],0.5755566984339222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,19637,31,0.95 [0.56-1.60],0.8353301970424635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,19255,29,1.16 [0.75-1.78],0.506612713606753
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,22785,32,4.27 [1.62-11.23],0.0032809111017835
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,19662,30,1.56 [0.79-3.09],0.2036255837956243
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,19567,30,1.12 [0.59-2.10],0.7355438377887944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,19121,30,1.30 [0.63-2.70],0.4785773293479931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,19118,29,1.63 [0.43-6.18],0.4696213198461229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,19118,29,0.48 [0.19-1.19],0.1140226733260695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,19121,30,1.31 [0.51-3.35],0.5785879404384672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,22075,32,1.18 [0.73-1.93],0.4985723539416364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22547,32,0.95 [0.69-1.32],0.7817361596459049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,22108,33,0.69 [0.35-1.33],0.2632952994378763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,18965,28,1.08 [0.47-2.47],0.8585751630781896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,19061,30,0.97 [0.51-1.86],0.9382160579569448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,19061,30,0.78 [0.44-1.37],0.3792057510884746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,19061,30,1.09 [0.64-1.86],0.7502120791244927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,22276,30,0.87 [0.70-1.10],0.2442445142501036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,19070,31,0.60 [0.23-1.53],0.2834406632811159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,19118,29,0.88 [0.46-1.69],0.6987806576055031
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,22835,33,1.16 [0.75-1.81],0.5027762458445779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,19061,30,1.75 [1.28-2.40],0.000443979202878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,19118,29,0.99 [0.51-1.92],0.9652712842384784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,22160,32,1.01 [0.42-2.47],0.9751663460903744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,19070,31,0.77 [0.34-1.74],0.5287102571335582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,19561,30,1.53 [0.92-2.55],0.1022455174608548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19628,31,1.19 [0.61-2.33],0.6100755117096509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",22521,34,0.88 [0.67-1.17],0.384742165955717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,19121,30,0.77 [0.31-1.94],0.5859226627589245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,19255,29,0.78 [0.20-3.07],0.7238275338935989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,22785,32,0.65 [0.38-1.09],0.1000563941237237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,22858,34,1.30 [0.47-3.59],0.6106781992329444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,22405,31,0.91 [0.45-1.85],0.7927132840657402
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,22482,31,1.12 [0.77-1.63],0.5579821834078741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,19628,31,0.77 [0.46-1.29],0.3259923030552847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,19637,31,0.94 [0.48-1.86],0.8597412054403537
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,22858,34,1.43 [0.81-2.52],0.219452346950999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,22656,33,2.45 [0.93-6.44],0.0694746429613994
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,19169,30,0.48 [0.19-1.17],0.1058076145791242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,19169,30,1.16 [0.62-2.15],0.6414676970923798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,19169,30,1.08 [0.61-1.91],0.7955808130208147
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,18973,28,1.19 [0.61-2.34],0.6103676147391073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,22767,33,0.76 [0.52-1.10],0.1448340326552061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,19628,31,1.05 [0.66-1.66],0.8447462838614823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,22482,31,0.77 [0.53-1.11],0.160256594443893
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,19567,30,0.81 [0.46-1.43],0.4631609708127975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,19255,29,0.91 [0.47-1.77],0.7863964281625802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,19063,28,0.69 [0.44-1.08],0.1039088638859772
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,22185,33,0.70 [0.36-1.36],0.2937814415311107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,19628,31,0.92 [0.37-2.29],0.852367954114521
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,19169,30,0.88 [0.58-1.36],0.5735369279160729
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,19567,30,1.07 [0.68-1.69],0.7635817417388416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,22548,32,0.76 [0.21-2.73],0.676144677786428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,19061,30,0.94 [0.63-1.40],0.7482606100069433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,19567,30,0.71 [0.54-0.96],0.0231360229119843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,19637,31,1.05 [0.56-1.96],0.8782502658386416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,22436,31,1.62 [1.05-2.51],0.0291971447706894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,19628,31,1.32 [0.73-2.40],0.363444029917126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22655,32,0.99 [0.55-1.79],0.97257576704799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,19121,30,1.07 [0.41-2.76],0.8923651581628255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,19061,30,0.74 [0.48-1.14],0.1713104461880112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,19628,31,0.89 [0.69-1.14],0.3486079498757992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,22588,34,0.93 [0.72-1.20],0.5762254571279115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,22388,31,0.82 [0.45-1.49],0.5088579508516535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,22482,31,1.85 [0.63-5.42],0.2641837428972227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,22547,32,1.72 [0.75-3.94],0.1991479272970721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,22142,34,0.67 [0.24-1.89],0.4437553824633812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,22482,31,1.81 [0.69-4.73],0.2281554767781533
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,22400,34,1.34 [0.80-2.24],0.2669739314899508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,22858,34,1.94 [0.57-6.63],0.2911328579559756
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,22714,33,1.50 [0.99-2.26],0.0546450814515204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,22436,31,1.53 [0.74-3.14],0.2477026898240435
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,22482,31,0.77 [0.43-1.39],0.383046456009263
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,22350,33,2.29 [0.96-5.45],0.0621151563031927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,19637,31,6.12 [2.84-13.23],3.98659926497804e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,22595,33,0.61 [0.19-1.90],0.3899342675946424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,22719,33,1.40 [0.56-3.53],0.4726956291539346
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,22402,31,1.08 [0.59-2.01],0.7976274035138935
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,19255,29,0.73 [0.48-1.10],0.1338958884324544
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,19533,30,1.44 [0.67-3.10],0.3546262336291207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,19121,30,0.67 [0.34-1.31],0.2406593638097084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,22482,31,4.86 [2.12-11.11],0.0001843385820999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,19667,31,0.90 [0.55-1.49],0.6896219258979303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,22185,33,0.76 [0.45-1.29],0.3118381443425652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,19561,30,0.45 [0.17-1.18],0.1060419582958855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,19121,30,0.69 [0.34-1.37],0.2832099219393977
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,22025,31,0.71 [0.45-1.14],0.1560657178598723
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19567,30,0.78 [0.55-1.10],0.1612373754244582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,19628,31,1.42 [0.69-2.93],0.3416985291877599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19561,30,0.86 [0.38-1.93],0.7099716906053455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,19121,30,1.15 [0.77-1.70],0.4937766184436641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,19561,30,0.75 [0.33-1.70],0.491594795186556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22436,31,0.86 [0.61-1.21],0.3957078213935805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,22748,33,3.03 [1.41-6.51],0.0043905471918058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,22025,31,0.78 [0.31-1.95],0.5896295424146787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19667,31,0.98 [0.62-1.57],0.9411196193505192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",19169,30,1.27 [0.90-1.80],0.1807018030751229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,19070,31,0.93 [0.52-1.65],0.7927177136665698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,19132,30,1.17 [0.44-3.12],0.7468777379538356
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,19061,30,0.71 [0.30-1.67],0.4286865393164371
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,22787,33,1.65 [0.72-3.81],0.2378590310873751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,22547,32,0.71 [0.50-1.01],0.0574085388234058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,19561,30,1.00 [0.44-2.30],0.9924401151677728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19070,31,0.44 [0.13-1.51],0.1938156557429235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,19637,31,1.02 [0.63-1.64],0.9353436321677412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22185,33,0.85 [0.33-2.19],0.7346092011549735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,19169,30,1.69 [0.51-5.56],0.3883091436946446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,19118,29,1.31 [0.71-2.41],0.3897229049925932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,19667,31,0.90 [0.61-1.31],0.5763487599295951
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,19567,30,1.37 [0.44-4.25],0.5910551566930742
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,19289,30,0.50 [0.16-1.52],0.2201852770897951
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22611,34,0.92 [0.34-2.52],0.8775297061408142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,19637,31,2.22 [1.18-4.20],0.0140312235043868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,22561,33,2.32 [0.80-6.70],0.120595550012207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,22401,31,9.96 [5.89-16.87],1.1424671896012493e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,19121,30,1.43 [0.99-2.06],0.0576382572253271
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,22550,32,0.77 [0.57-1.03],0.0745917030345149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,22075,32,0.55 [0.24-1.25],0.1537058786617846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,19567,30,1.50 [0.54-4.15],0.4355703969397367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,22858,34,0.74 [0.30-1.78],0.4956066198162031
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,22547,32,1.61 [1.21-2.15],0.0012241805751113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,19667,31,0.82 [0.51-1.32],0.4152501685895678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,19169,30,0.78 [0.58-1.04],0.0892192007525615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19628,31,0.95 [0.50-1.81],0.8733898404972724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19499,30,0.73 [0.52-1.04],0.0793992949941673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19070,31,1.09 [0.66-1.80],0.7350631375964948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19169,30,1.17 [0.53-2.60],0.7037014214418963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,22436,31,0.99 [0.57-1.71],0.9632268295608096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,19118,29,0.90 [0.61-1.35],0.6195142575490518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22588,34,1.27 [0.82-1.96],0.2881342159736283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22835,33,0.89 [0.66-1.22],0.4763882845088484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19637,31,0.96 [0.57-1.62],0.8715492868495682
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,19070,31,0.62 [0.25-1.55],0.3103486640173638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,22160,32,0.77 [0.24-2.43],0.6568879324283404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,19637,31,0.91 [0.61-1.36],0.6342781696260791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,19061,30,0.73 [0.45-1.17],0.1859519598309091
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELN,Elastin,19667,31,1.27 [0.48-3.35],0.6280996932972027
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,22482,31,2.17 [1.76-2.67],2.3560902213539653e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,19070,31,0.61 [0.21-1.72],0.3464333949012308
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,22160,32,0.58 [0.28-1.18],0.1325538712857608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,18162,26,0.74 [0.34-1.63],0.4528055794453001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,22858,34,8.46 [1.57-45.50],0.0128145336452135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,22551,31,0.79 [0.53-1.18],0.2458426594757771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,22785,32,0.63 [0.39-1.04],0.0714282492174785
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,19169,30,1.17 [0.66-2.09],0.5928337808838419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,19561,30,0.71 [0.33-1.49],0.3617578744636637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19070,31,2.39 [1.23-4.66],0.0104532624732671
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,19070,31,0.53 [0.17-1.62],0.265228127135426
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22858,34,1.64 [0.61-4.40],0.3216837773831992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22689,32,1.19 [0.53-2.68],0.6799561418340645
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19169,30,1.72 [0.66-4.46],0.2643294530079692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21886,28,1.31 [0.89-1.93],0.173189026908706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,19561,30,0.61 [0.29-1.31],0.2054355796871476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22075,32,0.73 [0.36-1.48],0.384095883201118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22185,33,1.79 [0.39-8.15],0.4524168856717766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22185,33,6.04 [1.92-19.02],0.0021318843102964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,19169,30,2.36 [1.57-3.54],3.303322680388087e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,19118,29,1.09 [0.36-3.29],0.8773464494447496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,19121,30,0.92 [0.51-1.67],0.7853848796799857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,22584,32,1.03 [0.76-1.39],0.8694590592676437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,19561,30,0.68 [0.24-1.92],0.4604896090198583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,22655,32,0.85 [0.34-2.10],0.718090765252505
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,22025,31,1.28 [0.89-1.84],0.1904636686119316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,21781,31,2.50 [1.26-4.94],0.0086083306479457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,19255,29,7.08 [2.33-21.57],0.0005713612316437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,22858,34,2.80 [0.90-8.72],0.076236078204543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,22388,31,4.61 [1.82-11.67],0.0012582171242265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,22185,33,1.08 [0.69-1.71],0.7334004768529572
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,19289,30,0.44 [0.15-1.35],0.1532255902381459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,22547,32,1.21 [0.85-1.73],0.2832488395591759
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,19169,30,0.81 [0.49-1.34],0.4088553151016971
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22753,33,4.77 [2.51-9.09],1.93125106014178e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,22656,33,1.13 [0.31-4.12],0.8501123657531447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,22520,32,0.46 [0.09-2.43],0.3643045747326662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,22656,33,0.93 [0.26-3.37],0.9099025530547558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,22482,31,0.81 [0.59-1.10],0.171297123653492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,19121,30,0.55 [0.27-1.10],0.0920800296207069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,18973,28,0.57 [0.16-2.02],0.3850396158142544
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,22388,31,0.74 [0.48-1.15],0.1762306126166548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,19289,30,2.25 [1.13-4.49],0.0211109636327175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,19118,29,1.17 [0.53-2.58],0.6987248824722101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19561,30,0.68 [0.26-1.75],0.4232445172403366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,19255,29,0.77 [0.57-1.05],0.0987531018466261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,22442,31,0.45 [0.13-1.59],0.2150884512709953
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19070,31,0.68 [0.28-1.66],0.3988718077452933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,22858,34,1.47 [0.57-3.77],0.4277034647769714
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,22580,32,1.73 [0.70-4.28],0.2339237718570667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,18973,28,0.86 [0.42-1.77],0.6902559944149339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,19118,29,1.28 [0.82-2.00],0.2706191745344972
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,19628,31,0.86 [0.56-1.33],0.4986677422119168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,18973,28,1.43 [0.81-2.54],0.2202305942789358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,19118,29,0.81 [0.54-1.22],0.3241550967510674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,19289,30,0.48 [0.14-1.69],0.2515981973462576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,19070,31,1.04 [0.60-1.80],0.889926850301551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,19070,31,0.61 [0.25-1.50],0.2794634814837041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,22785,32,13.03 [6.71-25.30],3.337972901206731e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,19671,31,0.91 [0.24-3.42],0.885575844164602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,19408,30,1.43 [0.66-3.07],0.364935444626894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,22595,33,0.86 [0.49-1.50],0.5950279376895578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,19696,31,0.56 [0.27-1.16],0.1175967278862448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,19578,30,0.61 [0.16-2.36],0.471105690641985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,19696,31,0.47 [0.05-4.45],0.5120155458966047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,22650,32,0.70 [0.40-1.23],0.2134715152469644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,22652,33,1.48 [0.51-4.27],0.4700993980969811
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,22621,34,0.34 [0.14-0.84],0.0196289131522183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,22613,34,0.50 [0.09-2.64],0.4113861497269656
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",22580,32,1.28 [0.93-1.76],0.1282768843171992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",22588,34,1.40 [0.97-2.02],0.0714477203211262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",19667,31,1.98 [1.15-3.40],0.0137354259699666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",22858,34,1.28 [0.70-2.31],0.4229070603902174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,22718,32,0.87 [0.55-1.39],0.5602170102159226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,22152,33,0.70 [0.38-1.28],0.243444973211283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,22547,32,1.25 [0.73-2.15],0.4118460977506201
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,22588,34,0.89 [0.59-1.33],0.5674976334722751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,19567,30,0.62 [0.35-1.10],0.1049703762361958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,19637,31,0.86 [0.67-1.10],0.2325959831704453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,19561,30,1.15 [0.36-3.72],0.8136547240879793
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,19169,30,0.80 [0.45-1.43],0.4505887898140445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,19667,31,0.88 [0.26-3.02],0.8398858118461773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,22482,31,1.01 [0.41-2.45],0.9875030736745608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,22554,34,2.26 [0.84-6.05],0.1048342638396047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,19567,30,0.74 [0.48-1.15],0.1858084415007803
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,22858,34,0.86 [0.28-2.64],0.7896015261629132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,19121,30,0.75 [0.42-1.35],0.3394319176482905
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,22790,34,1.65 [0.97-2.79],0.0621286298988611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,22835,33,0.74 [0.33-1.67],0.4655681348958627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,19662,30,2.39 [0.85-6.75],0.100529858734467
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,19121,30,1.03 [0.57-1.86],0.927558535757113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",22588,34,1.07 [0.72-1.61],0.7288147247905001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19667,31,2.40 [1.66-3.47],3.31231690927928e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,22547,32,0.66 [0.34-1.29],0.2275916803046503
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19637,31,2.45 [0.83-7.19],0.1034896930415138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,22595,33,2.23 [1.80-2.77],3.255643151099629e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22474,34,0.65 [0.47-0.90],0.0098260245764881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22075,32,1.78 [1.27-2.50],0.0007578651661649
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22582,34,1.04 [0.57-1.90],0.9012760498762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,19629,30,0.83 [0.48-1.43],0.5010507230621826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,22461,34,0.55 [0.34-0.88],0.0120650975843435
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,22588,34,20.21 [13.32-30.66],2.0775138855619984e-45
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,22728,33,2.41 [1.95-2.98],3.2282769271742223e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,22160,32,5.93 [4.39-8.02],4.237893939511018e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,22595,33,7.37 [4.95-10.97],7.964390998171437e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,22547,32,1.57 [0.98-2.50],0.0599771568143284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,22075,32,1.83 [1.40-2.39],9.663384463467182e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",19070,31,1.18 [0.74-1.88],0.4850113276977441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",19070,31,1.06 [0.60-1.89],0.8305972796850045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,22075,32,1.49 [1.15-1.93],0.002823493079022
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,22075,32,0.59 [0.28-1.25],0.167144851390567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,22613,34,1.14 [0.45-2.87],0.785404658257782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,19227,30,0.66 [0.21-2.09],0.4752589534251454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19637,31,0.96 [0.62-1.48],0.8528031923574492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,19118,29,0.92 [0.40-2.15],0.8545876329596719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,19118,29,0.61 [0.25-1.47],0.2713582001379296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,22689,32,0.78 [0.52-1.17],0.2362155850607048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,22547,32,1.41 [0.91-2.19],0.1250554917794817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,19118,29,0.68 [0.25-1.88],0.4623083228119123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,22748,33,1.13 [0.87-1.46],0.352538237902285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,22755,33,1.44 [0.97-2.13],0.0706756694665556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,19118,29,1.07 [0.36-3.24],0.9008294223102074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,22160,32,0.56 [0.20-1.51],0.2501551612640747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,19118,29,0.35 [0.10-1.27],0.1101841677012945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,18973,28,0.79 [0.45-1.39],0.4129845659266361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,18935,28,0.64 [0.30-1.37],0.251700394687282
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,22656,33,0.65 [0.25-1.70],0.3816644080430627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,19662,30,0.97 [0.48-1.96],0.940477071329814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,19628,31,2.14 [0.86-5.30],0.1007732903518398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,22656,33,2.95 [0.79-11.01],0.1083366845331557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,19255,29,1.04 [0.53-2.01],0.9175484938950142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,19671,31,1.08 [0.63-1.85],0.7816701845108427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,22025,31,0.70 [0.35-1.37],0.2963131446620046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",19061,30,1.06 [0.72-1.55],0.7818384582833429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,19070,31,0.50 [0.21-1.15],0.1036226723244568
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,22025,31,0.69 [0.45-1.05],0.0826565722670759
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,22587,32,0.62 [0.40-0.96],0.0318966949112858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19637,31,0.87 [0.61-1.23],0.4201940162060303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22654,33,0.83 [0.63-1.11],0.210888540009609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22436,31,1.35 [0.65-2.78],0.4224346995767108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22436,31,0.84 [0.60-1.18],0.3163948367331176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,21977,31,0.43 [0.18-1.04],0.061756269433701
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,19567,30,0.61 [0.33-1.15],0.1266034016384679
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,22075,32,0.87 [0.65-1.18],0.3677652132807923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22436,31,5.42 [1.94-15.09],0.001232884489308
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,22442,31,1.32 [0.33-5.29],0.6967457657064058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,22075,32,1.71 [0.94-3.13],0.0803413899542486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,22835,33,1.60 [0.62-4.11],0.3272117310572683
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,22656,33,0.77 [0.31-1.91],0.5764529416941316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,22025,31,1.27 [0.88-1.83],0.1943913821833058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,22075,32,1.54 [0.65-3.65],0.3303881606491557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,19696,31,0.53 [0.14-1.97],0.3425621498755719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,19628,31,1.54 [0.72-3.30],0.264559327662595
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19561,30,1.03 [0.39-2.75],0.9518194949304066
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,19118,29,1.13 [0.87-1.47],0.3477117317484858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,22549,33,1.92 [0.67-5.46],0.2238009721325888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,22785,32,1.95 [0.70-5.40],0.1989613953252886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,22583,33,1.05 [0.91-1.22],0.4938393901462857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,18935,28,0.43 [0.16-1.17],0.1003711895337399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,22025,31,0.76 [0.30-1.91],0.5550016759235745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,19118,29,1.85 [1.08-3.16],0.0251348379981477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,22547,32,1.14 [0.79-1.65],0.4767957962619501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,22075,32,1.04 [0.75-1.43],0.8330870622112627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,19070,31,0.94 [0.57-1.56],0.8122381834485177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,19121,30,1.33 [0.54-3.31],0.5355322572852853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,22361,31,4.77 [1.25-18.12],0.0218721984485308
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,19169,30,0.93 [0.55-1.56],0.7846012278267742
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FST,Follistatin,22650,32,0.52 [0.27-1.01],0.0541337597252155
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,19169,30,3.08 [1.17-8.10],0.0223322021276425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,22547,32,1.25 [0.46-3.40],0.6608409120716474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,19600,31,1.22 [0.83-1.77],0.3103391042909702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,22731,34,0.71 [0.52-0.97],0.0325055702716193
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,19255,29,1.80 [1.11-2.91],0.0164273811125543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FURIN,Furin,22656,33,0.55 [0.22-1.38],0.2044934402265673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,22044,32,3.28 [2.15-4.98],2.9166437149344665e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19246,30,1.25 [0.82-1.90],0.2942394096482151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22785,32,2.30 [1.19-4.45],0.0134280502877209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",22436,31,0.87 [0.50-1.51],0.6233837935392689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",22787,33,0.85 [0.56-1.29],0.4448256164206137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,22160,32,0.74 [0.44-1.24],0.2562156240329615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,22560,33,0.79 [0.57-1.11],0.1694812645279485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,19121,30,0.88 [0.45-1.71],0.7035616595667709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,19061,30,1.10 [0.52-2.35],0.7955973607428637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,19561,30,0.91 [0.44-1.87],0.8019000560668997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19289,30,0.57 [0.26-1.25],0.1585163339945791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19061,30,0.82 [0.43-1.54],0.5369013807888235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,18973,28,1.11 [0.28-4.45],0.8774914059257275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,19118,29,1.26 [0.70-2.27],0.4490541449289966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19289,30,0.48 [0.16-1.47],0.2018634193533897
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19169,30,0.96 [0.49-1.89],0.9128927903618482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,18973,28,0.80 [0.41-1.58],0.5277995551876471
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,22689,32,0.51 [0.30-0.86],0.011178052694189
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22482,31,1.41 [0.45-4.43],0.5560699183014857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22787,33,2.53 [0.80-8.03],0.1140884061273767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22160,32,2.88 [1.56-5.34],0.000766940089902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19667,31,3.48 [1.42-8.50],0.0062575693782229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,22482,31,4.51 [1.44-14.11],0.0097288873025395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,19070,31,0.50 [0.14-1.73],0.2705745660812891
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18832,27,0.53 [0.21-1.30],0.1655177404568227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,19637,31,0.85 [0.22-3.28],0.8120575651630688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,19289,30,0.75 [0.33-1.70],0.4909709460418769
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,22710,33,2.04 [0.61-6.77],0.245938816773288
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,19070,31,1.01 [0.45-2.25],0.977253198831968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,19628,31,0.96 [0.74-1.25],0.7780847417493856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,18973,28,1.13 [0.29-4.35],0.861039735988962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19169,30,1.10 [0.71-1.72],0.664228576675706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,19121,30,1.18 [0.63-2.21],0.6045356097508624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,19591,31,1.84 [1.26-2.71],0.0017435620816132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,22160,32,1.02 [0.60-1.72],0.9531523448734498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,22025,31,0.81 [0.41-1.61],0.5565214433490253
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,19070,31,0.67 [0.26-1.73],0.4044019103858913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,19696,31,0.74 [0.19-2.78],0.6508883262472688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,19628,31,0.83 [0.61-1.14],0.2578293868263501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,22075,32,0.90 [0.70-1.17],0.4394453790223215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18785,26,1.86 [1.23-2.80],0.0031544009586473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,19070,31,1.14 [0.59-2.19],0.6986874140938795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22482,31,2.01 [0.85-4.76],0.1139460859644556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,22858,34,1.89 [1.25-2.85],0.0023911385432889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,22588,34,0.54 [0.23-1.29],0.1682235711906919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,22025,31,1.00 [0.43-2.34],0.9962059633100212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,19667,31,1.37 [0.84-2.24],0.2036701538077425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,22039,32,1.32 [0.69-2.53],0.3970127224304485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,22075,32,1.17 [0.72-1.89],0.529440637649069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22075,32,1.02 [0.80-1.29],0.8958320314515987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,22748,33,3.37 [1.22-9.31],0.0192965552183668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,22482,31,1.65 [0.39-6.97],0.4978448964591082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,22370,31,1.47 [0.50-4.35],0.4826819420090067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,19039,31,1.63 [1.04-2.56],0.0324534320716365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,22025,31,0.42 [0.20-0.87],0.018763004006598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,19667,31,0.95 [0.58-1.55],0.8349483342775064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,19624,31,1.07 [0.53-2.17],0.8460125055864332
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,22188,34,2.20 [1.20-4.03],0.0106359322294192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,22561,33,0.87 [0.45-1.68],0.6756618342503925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,22436,31,1.85 [0.52-6.56],0.3435684717760924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,22554,34,1.06 [0.89-1.26],0.4894575627528932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,22075,32,0.71 [0.54-0.94],0.017762499018977
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,19255,29,0.75 [0.21-2.61],0.6493700345775146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,22025,31,0.59 [0.27-1.30],0.1914095750733503
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,22588,34,1.13 [0.77-1.65],0.5394189053476148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,19637,31,0.72 [0.21-2.44],0.5919532832794585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,19637,31,1.08 [0.70-1.69],0.7207597845031726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,19255,29,1.27 [0.48-3.33],0.6319618360359742
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,18973,28,0.90 [0.43-1.88],0.7875275079466919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,19169,30,0.79 [0.40-1.55],0.4930216027207311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,19628,31,1.82 [0.61-5.45],0.2865825640436816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,19567,30,0.67 [0.48-0.93],0.0179630939952781
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,19118,29,0.62 [0.24-1.59],0.3236041360098263
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,19118,29,1.04 [0.72-1.51],0.8307617266416214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,18973,28,0.68 [0.34-1.39],0.2963632739542055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,21600,31,0.85 [0.27-2.70],0.7790025482096842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,19212,29,0.96 [0.35-2.60],0.9290228273002732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,22436,31,1.17 [0.54-2.54],0.6868290950940018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,19118,29,1.83 [0.99-3.39],0.0544479819383724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,22185,33,1.07 [0.64-1.80],0.7944228440157255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,22548,32,0.66 [0.28-1.57],0.3446714418662692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,19061,30,1.79 [1.02-3.17],0.0442722369130937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,22438,34,1.52 [0.93-2.48],0.0918707627886105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19255,29,1.10 [0.74-1.64],0.6396945057964887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22025,31,0.57 [0.23-1.40],0.218153537430466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,19561,30,1.52 [1.04-2.24],0.0321253705681074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,19186,28,1.62 [1.01-2.60],0.0454633604427312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,19667,31,0.79 [0.49-1.27],0.3252421041966054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,22835,33,1.02 [0.56-1.86],0.9613938665118952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,19255,29,0.96 [0.57-1.64],0.8850261401092566
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,19637,31,0.47 [0.26-0.87],0.0157941171813998
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22075,32,0.80 [0.48-1.33],0.3912726472365373
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19121,30,0.75 [0.32-1.74],0.498836939067242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,22595,33,1.70 [0.98-2.96],0.0583784533966873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,19169,30,1.15 [0.43-3.05],0.7859811642164962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,19255,29,1.29 [0.49-3.42],0.603610520412998
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,19637,31,1.27 [0.85-1.92],0.2444415552244723
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,22785,32,2.45 [0.71-8.48],0.1567780240654623
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22547,32,0.80 [0.59-1.09],0.1510148172830099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,19567,30,0.46 [0.20-1.04],0.0633618220334401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",19662,30,2.10 [1.34-3.29],0.0012415447388444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,22461,34,0.56 [0.21-1.47],0.2366892342334612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,19070,31,0.77 [0.46-1.29],0.3211925634344159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,21909,31,0.95 [0.65-1.39],0.7841699121154433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,19255,29,0.48 [0.19-1.20],0.1153998952870458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,22560,33,0.80 [0.57-1.14],0.2162879128804293
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,22482,31,1.01 [0.80-1.27],0.9286845826476208
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,22787,33,2.43 [0.86-6.91],0.0955605845344693
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,22436,31,0.69 [0.39-1.21],0.1949726336953517
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,19561,30,1.39 [0.74-2.62],0.2998688392392206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,19567,30,1.17 [0.62-2.21],0.6190860204591357
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,19671,31,1.16 [0.57-2.36],0.6901142061586315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19567,30,1.06 [0.63-1.76],0.8349237273125513
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,22025,31,2.20 [1.28-3.77],0.0041470938240768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,21975,34,3.72 [1.30-10.71],0.0146902336757864
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,19061,30,0.78 [0.38-1.60],0.5016107104685328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,19637,31,1.58 [0.81-3.11],0.1816420915180338
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,19567,30,1.01 [0.57-1.79],0.9669093614149028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,22185,33,1.11 [0.70-1.76],0.6702350987556163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,19561,30,0.79 [0.39-1.61],0.5195004687877769
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,22588,34,0.90 [0.71-1.14],0.3757273795333959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19667,31,1.03 [0.61-1.76],0.9107874437794304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",19637,31,0.97 [0.43-2.16],0.9337214257462432
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19061,30,0.84 [0.41-1.72],0.6354308690076369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,22185,33,0.86 [0.44-1.67],0.6580610861788436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,22498,33,13.02 [6.28-27.01],5.331758177885568e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,19169,30,0.71 [0.37-1.34],0.2836067270998509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",22482,31,1.39 [0.86-2.23],0.1740406653997811
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,18867,28,0.63 [0.37-1.06],0.0804376323011175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,22075,32,1.11 [0.82-1.50],0.5060631881498804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,19602,31,2.75 [0.56-13.49],0.2122238487726389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",19551,30,4.26 [0.96-18.94],0.0566808197003734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,22553,34,1.16 [0.83-1.64],0.3792160946790204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,22075,32,1.07 [0.72-1.59],0.7245694353830714
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,19070,31,0.81 [0.46-1.45],0.4812787261669923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,21889,31,1.14 [0.74-1.76],0.5397041475886788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,19628,31,1.06 [0.92-1.23],0.4023059610526005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19289,30,1.13 [0.75-1.69],0.5514378164572494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,19121,30,0.83 [0.53-1.31],0.430593103108841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,22486,33,0.56 [0.22-1.38],0.2071153429213557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,19289,30,0.91 [0.57-1.43],0.6707755398575643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,19070,31,0.79 [0.29-2.18],0.6547706621370574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,22696,34,0.98 [0.59-1.63],0.9436688025825686
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",22185,33,0.93 [0.66-1.30],0.6622214297307014
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,22835,33,2.72 [1.58-4.69],0.0003103439548245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,22547,32,1.04 [0.65-1.67],0.8793035041395456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,22185,33,1.40 [1.09-1.82],0.0095311601846905
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,18973,28,0.47 [0.16-1.44],0.1890648505333
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19070,31,0.53 [0.23-1.25],0.1478794770873388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22715,33,1.08 [0.72-1.61],0.7238682465334725
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,22787,33,1.13 [0.90-1.42],0.2773557542456131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",22595,33,0.84 [0.56-1.25],0.3800016672310297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,22754,33,1.47 [0.91-2.36],0.1125449991671466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,22595,33,3.59 [1.78-7.26],0.0003556116426529
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,22715,33,0.74 [0.48-1.13],0.1600956156477245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,22787,33,1.33 [0.84-2.12],0.2236105514644892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,19667,31,1.09 [0.79-1.49],0.5995262949245507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,19070,31,0.68 [0.27-1.70],0.407325994956813
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,22835,33,0.96 [0.55-1.66],0.8719579170737632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,19118,29,1.16 [0.71-1.87],0.5548703544284839
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,19061,30,1.16 [0.75-1.81],0.5034654261313103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,19567,30,1.77 [0.92-3.39],0.0857397847492223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,22758,33,1.06 [0.77-1.46],0.7219187314112518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,19628,31,1.89 [1.28-2.80],0.0013801791730355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,22185,33,0.67 [0.35-1.29],0.2338452651423235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,19255,29,3.73 [0.99-13.99],0.0509148356338298
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,19628,31,1.73 [0.75-3.98],0.1992524909793414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,19667,31,0.66 [0.17-2.53],0.5482271452850078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,22547,32,0.98 [0.66-1.44],0.9158188690279948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,22835,33,2.15 [0.95-4.83],0.0648463031390534
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,19477,30,0.84 [0.28-2.52],0.7622155310701975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22075,32,0.62 [0.40-0.97],0.0367038240929641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,19628,31,0.99 [0.63-1.55],0.9516005600901906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,19118,29,1.01 [0.60-1.72],0.9630275270078446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,19070,31,0.60 [0.17-2.06],0.4149937982556675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,19593,31,1.36 [0.71-2.60],0.3485904332698332
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,19637,31,0.91 [0.40-2.03],0.8110813286124988
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,22185,33,0.73 [0.24-2.23],0.5753465973990798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19637,31,7.36 [2.54-21.37],0.0002395081119008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22481,32,2.41 [1.16-5.00],0.0185224951082827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22547,32,3.55 [1.55-8.16],0.0028064002077917
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,22787,33,1.42 [0.72-2.78],0.3106301105420716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,19219,29,1.28 [0.67-2.42],0.4552649320713818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19169,30,1.40 [0.76-2.61],0.2816501411965226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19070,31,0.61 [0.25-1.50],0.2813939285186232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,18945,28,0.37 [0.13-1.03],0.0577280557101244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,22339,34,1.54 [0.83-2.84],0.1706140870054283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,22025,31,1.15 [0.60-2.21],0.6677329546171622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,19121,30,0.81 [0.43-1.51],0.5025860107625034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,22318,31,1.76 [0.93-3.34],0.0826285378144538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22120,33,1.22 [0.83-1.78],0.3050572629919896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19637,31,2.17 [1.58-2.99],1.6122367244005e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,22835,33,0.74 [0.50-1.09],0.1271190824299843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,22075,32,0.53 [0.23-1.25],0.1497745712193814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,19383,28,0.92 [0.62-1.35],0.6629193701916127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,19253,30,0.53 [0.26-1.07],0.078283524622957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19169,30,1.04 [0.39-2.75],0.9374939083596808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,19578,30,1.61 [0.54-4.81],0.3892448140970981
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,19169,30,0.81 [0.54-1.22],0.3163425377015792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22482,31,0.40 [0.18-0.91],0.0277244317285183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22787,33,1.72 [0.78-3.82],0.1801990613269356
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19118,29,1.88 [0.64-5.48],0.2509038945091163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,19169,30,0.79 [0.54-1.15],0.224287049406048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22547,32,1.11 [0.50-2.44],0.8046428600338567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19628,31,1.07 [0.62-1.84],0.8089598349267637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,19070,31,0.74 [0.34-1.64],0.4592679781226993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19169,30,1.39 [0.69-2.79],0.350424272824918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,21922,30,0.79 [0.43-1.44],0.4409911765924688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,22655,32,0.73 [0.46-1.16],0.1874061028233664
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,19561,30,1.48 [0.64-3.40],0.3557930619728069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,22221,33,0.95 [0.60-1.50],0.8336111465446643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,22787,33,2.21 [1.07-4.59],0.0324388743071124
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22393,34,1.17 [0.35-3.92],0.7998531991074942
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,19061,30,0.76 [0.43-1.34],0.3460858386662333
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,19061,30,1.16 [0.55-2.46],0.6921055391978372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",22656,33,0.86 [0.52-1.43],0.5661091838160278
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,22422,33,0.34 [0.09-1.32],0.1205366273506273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,22858,34,1.98 [0.50-7.84],0.3320890181737731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,22160,32,0.78 [0.51-1.19],0.2474126572473663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,22472,34,2.92 [1.20-7.13],0.0185058535296518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,22858,34,1.47 [0.55-3.93],0.4380483044233346
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,22858,34,2.40 [1.57-3.67],5.591340170209445e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,22547,32,0.77 [0.43-1.37],0.3797308586723676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,22588,34,1.16 [0.58-2.33],0.6679339076248748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,22482,31,14.16 [4.01-49.96],3.774935800952492e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,19289,30,0.58 [0.20-1.68],0.3126527075305609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,22025,31,1.35 [0.74-2.46],0.3293051275686158
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",19169,30,1.30 [0.82-2.09],0.2665358602066399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,22835,33,2.26 [0.05-97.04],0.6705516115543448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,22787,33,0.64 [0.34-1.20],0.1657131947466314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19086,30,3.77 [2.36-6.02],2.770735494456437e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19289,30,0.80 [0.58-1.11],0.1794048176894601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19289,30,1.09 [0.44-2.70],0.8594305718112417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,19567,30,1.72 [0.58-5.13],0.3275833044701307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,22160,32,1.12 [0.85-1.48],0.4043470358460856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,22689,32,4.54 [1.10-18.77],0.0365843887529646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,22436,31,0.54 [0.27-1.08],0.0824951931337794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,22025,31,1.63 [0.93-2.87],0.0864741499947092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,19061,30,1.27 [0.84-1.91],0.2585860186456629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,22547,32,2.63 [1.91-3.62],3.003389570541e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,19070,31,1.57 [0.88-2.79],0.1271821644459539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,19121,30,0.91 [0.40-2.08],0.824225460153505
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,19637,31,1.19 [0.69-2.05],0.5406758515578416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19061,30,1.45 [0.89-2.35],0.1367573942334004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19662,30,1.42 [0.36-5.58],0.6194330817989742
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,22482,31,2.13 [0.81-5.62],0.1261389472482136
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19070,31,0.69 [0.28-1.70],0.4184643183778745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,22595,33,3.05 [0.81-11.47],0.0982951484718233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,22819,34,1.15 [0.89-1.50],0.2779139958706226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,22819,34,1.60 [0.98-2.62],0.0625512544118077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,22650,34,0.38 [0.14-0.99],0.0468390652144799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,22299,32,1.30 [0.62-2.73],0.4883300487674191
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,22468,34,1.50 [0.54-4.21],0.4374552904082992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,22858,34,1.72 [0.68-4.35],0.2547809721743016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,22588,34,1.82 [0.79-4.22],0.1607914090550743
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,19118,29,0.70 [0.35-1.41],0.3202268942036154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,19070,31,0.44 [0.20-0.97],0.0418569363792456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,19657,31,0.35 [0.05-2.51],0.2945875136099692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,18973,28,0.51 [0.23-1.11],0.0914123839489749
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,19169,30,0.43 [0.15-1.27],0.1265358653843491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,22482,31,3.77 [2.92-4.86],1.9630896535150505e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,22588,34,1.83 [0.69-4.84],0.2208157896903829
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,19667,31,0.96 [0.63-1.49],0.8706998119839224
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,22547,32,0.98 [0.69-1.38],0.8921764333357015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,22075,32,1.16 [0.89-1.52],0.2665673503164067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,22160,32,1.42 [1.12-1.80],0.0036105920554381
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,22160,32,1.20 [0.79-1.80],0.3932983781418385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,22689,32,2.74 [1.52-4.96],0.0008559953123215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,22160,32,1.00 [0.62-1.63],0.9987808896548452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,22482,31,2.21 [1.64-2.97],2.1762660285256045e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,22835,33,3.20 [1.93-5.32],7.136551729937352e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,22160,32,2.41 [1.21-4.81],0.0123612175111751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,19118,29,1.60 [0.78-3.30],0.2029100368418895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,22160,32,0.38 [0.14-1.05],0.0616681220522511
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,22301,32,1.00 [0.22-4.64],0.9988531627483508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,19061,30,2.38 [0.85-6.68],0.1005655132458788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,22547,32,0.39 [0.15-1.06],0.0662336994838714
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,22160,32,1.46 [0.60-3.58],0.4076363947497411
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,22835,33,2.53 [1.69-3.79],7.359161838558584e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,22136,32,1.13 [0.57-2.22],0.7280747630162013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,22160,32,0.97 [0.62-1.52],0.8876487773100418
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,22160,32,1.73 [1.09-2.74],0.0203533718486456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,22160,32,0.54 [0.30-0.99],0.0453837000364488
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,22595,33,1.32 [0.66-2.66],0.4317711208480822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,22254,32,1.61 [0.90-2.88],0.1091037241323789
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,22505,32,1.54 [0.86-2.76],0.1457726632186082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,22650,34,3.71 [1.91-7.21],0.0001092971756084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,22835,33,1.01 [0.40-2.56],0.9759172403423148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,22290,31,0.92 [0.75-1.11],0.3753676470850657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,22024,34,1.24 [0.82-1.89],0.3084079318851934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,22160,32,1.13 [0.69-1.85],0.6384562265461275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,22059,32,1.08 [0.62-1.86],0.790101940212977
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,22561,33,2.23 [0.60-8.24],0.2293052042068241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,22551,32,1.37 [0.27-6.91],0.7041718921635894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,22595,33,0.67 [0.32-1.40],0.2867810801802926
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,22790,34,0.69 [0.36-1.32],0.2630508058158885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,22160,32,0.95 [0.43-2.11],0.9037917570560742
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,22546,32,1.35 [0.84-2.16],0.2161404782255072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,22160,32,1.13 [0.41-3.11],0.8192211870339771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,22160,32,1.34 [0.89-2.00],0.1565554512737446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,22160,32,0.33 [0.12-0.87],0.025996753846176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,19118,29,1.41 [0.66-3.02],0.3786848941024495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,19118,29,0.42 [0.15-1.19],0.1029033201045638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,19561,30,0.97 [0.57-1.66],0.919031649971803
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,22160,32,0.60 [0.25-1.45],0.2562320768103858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,22160,32,0.79 [0.39-1.63],0.5292529602915657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,18903,28,0.55 [0.20-1.53],0.2496471812765098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,22417,33,5.65 [3.27-9.78],6.075631133517154e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,22160,32,1.03 [0.46-2.27],0.9482776195375566
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,19561,30,1.45 [0.81-2.60],0.2139814454426049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,18973,28,0.88 [0.50-1.53],0.6426249026889086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,19118,29,0.34 [0.13-0.91],0.0312302048739684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,19043,29,1.17 [0.49-2.81],0.7173965745539322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,22547,32,0.95 [0.45-2.01],0.8931114447208772
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,22160,32,1.14 [0.51-2.57],0.7429980462010999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,21995,31,0.68 [0.29-1.55],0.3553333027006375
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,19118,29,0.80 [0.39-1.67],0.5570726816990168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,19035,28,0.46 [0.22-0.97],0.041728575175132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,22160,32,2.45 [1.13-5.34],0.0240369485627226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,22160,32,0.79 [0.63-0.99],0.0378116844399804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,22547,32,3.47 [2.19-5.50],1.173101866352312e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,22160,32,0.75 [0.57-0.97],0.0314470493208608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,22547,32,0.59 [0.32-1.07],0.0818788251751644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,22482,31,1.27 [0.90-1.77],0.1710889511137232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,22428,34,0.96 [0.39-2.36],0.9299647331046688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,22588,34,1.18 [0.21-6.63],0.8536426974557357
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,22547,32,0.47 [0.28-0.79],0.0043008820367899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,22595,33,0.74 [0.42-1.30],0.2925214976215543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,19289,30,0.99 [0.53-1.84],0.9789793223207816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22000,31,1.32 [0.80-2.19],0.2812688765418181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,19561,30,1.52 [0.84-2.77],0.1661066495423265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,22436,31,0.74 [0.43-1.27],0.2768294144445095
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,19628,31,0.99 [0.54-1.81],0.9634762279321898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,19061,30,0.53 [0.13-2.07],0.3589345252512694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,21977,31,2.01 [1.45-2.78],2.685123650917108e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,19255,29,0.86 [0.42-1.75],0.6702232638005005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,22595,33,0.74 [0.37-1.48],0.3947504340624632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,22482,31,0.89 [0.49-1.62],0.7041550660306539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19169,30,2.20 [1.30-3.73],0.0032711891207514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19637,31,0.86 [0.37-2.01],0.7280334073062485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22482,31,0.86 [0.62-1.20],0.3741282093548996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,19628,31,1.83 [0.89-3.77],0.1000411930122367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,19561,30,1.08 [0.58-2.02],0.7974544927780913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,19567,30,1.09 [0.76-1.57],0.6296176461696745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,19118,29,3.58 [0.47-27.54],0.2201106090283535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,22401,31,0.90 [0.63-1.28],0.5432262368064005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,22482,31,0.90 [0.50-1.62],0.7166197396307561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22185,33,1.35 [1.01-1.80],0.0410011800741298
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,22160,32,0.80 [0.50-1.30],0.3685590915470516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,22547,32,0.80 [0.60-1.07],0.1361338117208103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21717,31,2.54 [1.14-5.68],0.0232745795333874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,22547,32,1.42 [0.64-3.17],0.3916395905461272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,19662,30,1.00 [0.45-2.22],0.9926337436120684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,19427,30,0.73 [0.51-1.03],0.075046938104083
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,22547,32,0.96 [0.39-2.40],0.9312960870951336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,19255,29,0.53 [0.19-1.53],0.2411866342432862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,22595,33,2.73 [0.85-8.77],0.0910146876133345
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,22547,32,0.49 [0.24-0.97],0.0415724749010036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,19118,29,4.22 [1.86-9.57],0.0005621711919942
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,22595,33,0.45 [0.16-1.22],0.1152352558636678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,22787,33,1.96 [0.28-13.69],0.4992220970474486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,19289,30,1.21 [0.68-2.12],0.5165132805115273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,22542,34,0.71 [0.17-2.99],0.6386950064866653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,22075,32,1.18 [0.57-2.46],0.6582124857269822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,22185,33,0.88 [0.66-1.15],0.3404695816448401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,22440,34,2.08 [0.74-5.86],0.1636043478619606
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,22656,33,0.62 [0.26-1.49],0.2832465078429307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,22160,32,1.77 [0.61-5.10],0.2908444062316037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,22787,33,1.33 [0.70-2.52],0.3777170084606273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,19662,30,3.15 [1.43-6.95],0.004438083655005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19696,31,0.55 [0.09-3.39],0.5171664641402471
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22650,34,1.46 [0.64-3.33],0.3705082609733954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19696,31,0.98 [0.27-3.49],0.973979227125083
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19561,30,0.69 [0.29-1.67],0.4141003878540049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,22547,32,1.57 [0.96-2.58],0.0733151229922989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,19070,31,1.06 [0.64-1.76],0.825759630998939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19169,30,0.58 [0.31-1.08],0.0870349872430396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19061,30,0.62 [0.24-1.60],0.3273855789651648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22025,31,0.88 [0.45-1.73],0.7095030855204856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,18973,28,1.18 [0.61-2.28],0.6172135943018622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,22785,32,2.24 [0.74-6.77],0.1545319199831707
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,19255,29,0.80 [0.38-1.69],0.554556568749698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,22160,32,1.40 [0.86-2.28],0.1710103145918166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,18973,28,0.74 [0.35-1.54],0.4148739385054962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,19567,30,0.74 [0.50-1.11],0.1484416658219746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,22160,32,1.28 [0.80-2.04],0.3043385664062134
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22482,31,1.67 [0.78-3.59],0.1884301113685879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,19567,30,0.87 [0.62-1.21],0.4016951139104238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,19061,30,0.91 [0.46-1.78],0.7780330253222243
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,19121,30,0.65 [0.33-1.28],0.2116338072929048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,22025,31,1.36 [0.92-2.03],0.1261064611870163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,19266,31,2.27 [1.53-3.37],4.335154986564311e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,19118,29,1.15 [0.85-1.57],0.3625417955188412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,22656,33,0.84 [0.25-2.86],0.7853781188276557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,22025,31,1.24 [0.51-3.03],0.6384777140818358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,18973,28,1.00 [0.58-1.71],0.9999994091368544
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,19169,30,1.21 [0.70-2.10],0.5007506075176501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,19628,31,3.00 [1.82-4.93],1.5668791110682588e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,19289,30,1.00 [0.61-1.63],0.998599943582676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,19289,30,0.59 [0.16-2.20],0.4352945399463421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,19561,30,0.33 [0.11-1.00],0.0499334872845436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,19070,31,0.93 [0.33-2.60],0.8858301175807949
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,19061,30,1.16 [0.78-1.71],0.461950300959937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,19070,31,1.11 [0.83-1.49],0.4739848460039598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,22482,31,0.80 [0.55-1.16],0.2386329313714533
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19561,30,1.71 [1.16-2.51],0.0063770354252517
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22075,32,1.82 [1.26-2.64],0.001402732876746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19567,30,1.06 [0.87-1.29],0.5636715768683933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22075,32,0.97 [0.75-1.25],0.785727811261191
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,18973,28,0.72 [0.39-1.32],0.2856231268522074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,19061,30,0.98 [0.54-1.78],0.9465545985285008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,22025,31,1.23 [0.56-2.70],0.6096687222200352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,22613,34,0.31 [0.12-0.84],0.0209535491587597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,22588,34,2.27 [0.95-5.43],0.065820756562128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,22025,31,1.04 [0.68-1.61],0.8487454247604986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,19061,30,1.73 [0.91-3.26],0.0919639152022884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,19637,31,1.02 [0.50-2.09],0.9488976445863632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,22348,33,1.00 [0.79-1.27],0.9952472432455408
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,22584,33,0.75 [0.34-1.66],0.4721422290115852
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,22433,33,1.81 [0.86-3.83],0.1195932200023335
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,22075,32,1.03 [0.82-1.28],0.8228462810551629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,22084,30,0.77 [0.37-1.61],0.4904203546550009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,22787,33,0.98 [0.50-1.90],0.9504355454091582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,19536,30,1.45 [0.75-2.79],0.2727728124488564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,19662,30,1.29 [0.78-2.15],0.3209432456115315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,22787,33,1.38 [0.88-2.16],0.1618195905592226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,22629,33,1.51 [0.55-4.15],0.4264499611666358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,18733,27,1.54 [0.65-3.65],0.3219140893850071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,21829,33,0.98 [0.40-2.36],0.958454609952102
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,19297,30,0.35 [0.09-1.31],0.1192601727367949
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,22835,33,4.70 [2.32-9.53],1.80109395944445e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19061,30,1.17 [0.72-1.92],0.528520737272241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,22835,33,1.72 [0.89-3.34],0.1093209926729548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,19118,29,1.63 [1.05-2.53],0.029200148176419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,19628,31,2.21 [1.37-3.56],0.0011382417694208
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",21302,31,0.80 [0.46-1.37],0.4143558474634627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",19070,31,1.22 [0.53-2.82],0.6399175299901059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",22482,31,1.31 [0.91-1.87],0.1464498532855489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",22514,32,1.25 [0.80-1.93],0.3273986967185253
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",22025,31,1.14 [0.59-2.19],0.7011112972375474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",19070,31,0.56 [0.18-1.74],0.3204935943209344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",19061,30,1.28 [0.88-1.87],0.1930495568860905
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,22549,34,1.27 [0.76-2.13],0.3554332516401147
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,22835,33,1.90 [1.03-3.52],0.0404401744254262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,22656,33,9.54 [3.75-24.23],2.153737262522176e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19667,31,0.93 [0.63-1.36],0.6956321530972136
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,19524,30,0.94 [0.48-1.85],0.8644407123342601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,22588,34,0.91 [0.57-1.45],0.6840882074647747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,22482,31,3.16 [2.18-4.58],1.3686856685932178e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22580,32,2.39 [1.40-4.07],0.0013874296468366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22436,31,0.95 [0.71-1.27],0.7352913868717352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,19070,31,1.11 [0.63-1.95],0.7088767099758585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,22689,32,0.41 [0.15-1.13],0.0837130586096151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,19169,30,1.03 [0.31-3.40],0.9582632327944456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,19111,28,0.36 [0.06-2.08],0.2505562411195712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,21900,31,0.44 [0.08-2.42],0.3440910748885818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,22795,33,1.17 [0.63-2.17],0.6115889463229781
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,19561,30,0.86 [0.35-2.12],0.7413997054537573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,22160,32,0.96 [0.49-1.88],0.9120373616883668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,19561,30,0.99 [0.57-1.73],0.9822882271411588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,22835,33,0.70 [0.49-1.02],0.0644014959689514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,22482,31,0.82 [0.63-1.07],0.1442462625540963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,19118,29,0.89 [0.58-1.38],0.6126752683878582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,22388,31,3.12 [1.44-6.74],0.003839370774418
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,22650,34,1.55 [0.94-2.55],0.0857680138028259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,22785,32,1.00 [0.63-1.58],0.9927982434715812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,19671,31,0.64 [0.18-2.26],0.4871679488001021
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,19637,31,1.17 [0.73-1.89],0.5098103008842048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,21884,33,1.39 [0.65-2.99],0.3966100420836662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,19662,30,1.37 [0.70-2.68],0.3614824880591352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,22649,34,0.71 [0.39-1.29],0.2601057310249268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,19637,31,0.82 [0.58-1.18],0.2898036827854923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,19667,31,0.50 [0.29-0.85],0.0111066875747665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,22748,33,0.99 [0.53-1.83],0.962145846806326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,18593,26,0.84 [0.47-1.48],0.542137525494301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,19061,30,0.82 [0.47-1.42],0.4746157567633734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,19637,31,1.81 [1.24-2.62],0.0018800580122841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEP,Leptin,22588,34,0.65 [0.41-1.02],0.0593281271741733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,22588,34,1.03 [0.38-2.80],0.9483372702276376
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,19637,31,1.33 [0.73-2.41],0.3472844625467199
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,22588,34,1.92 [0.85-4.35],0.1171154912626964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,22640,33,0.98 [0.35-2.75],0.9710235804484024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,19696,31,1.78 [0.78-4.10],0.1729546457618803
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,22580,32,1.19 [0.67-2.12],0.5578817912553444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,22548,31,0.92 [0.41-2.08],0.8396810503361507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,22785,32,0.86 [0.50-1.47],0.5837397726246976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,22582,32,2.57 [1.08-6.11],0.0329199052439022
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,22689,32,0.80 [0.33-1.94],0.6259339075778202
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,22075,32,1.09 [0.77-1.53],0.6380794686168995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22614,32,1.15 [0.69-1.92],0.5805912760887273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,22025,31,0.89 [0.46-1.73],0.7397761801826573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,22547,32,1.51 [0.43-5.33],0.5174500447418315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22595,33,1.71 [0.69-4.22],0.2484301045834297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19662,30,1.01 [0.78-1.30],0.942226660794414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19070,31,0.92 [0.45-1.88],0.8120638925849787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22554,34,0.94 [0.36-2.45],0.9002718921880968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19667,31,1.14 [0.71-1.82],0.5859931133030565
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22858,34,9.95 [3.73-26.59],4.560796999576378e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22751,34,2.78 [1.10-7.02],0.0306105601232004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22160,32,1.41 [0.70-2.83],0.3412383233954881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,22858,34,1.30 [0.82-2.07],0.2710429091910016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,19169,30,1.01 [0.57-1.80],0.9769822580746416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,19524,30,1.24 [0.76-2.02],0.3850722252638227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,19628,31,2.86 [1.12-7.30],0.0281936993402275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,19637,31,1.67 [0.84-3.35],0.1452042359698496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,19061,30,0.43 [0.21-0.87],0.0187074024582897
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",19169,30,0.98 [0.65-1.48],0.9210393649188232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),19203,30,0.95 [0.78-1.16],0.6272026078670958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,22482,31,1.16 [0.59-2.27],0.6743911679379619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,22588,34,0.94 [0.49-1.79],0.8539911547342272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,21886,31,0.70 [0.41-1.20],0.1990078656432161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,19070,31,0.75 [0.44-1.29],0.2999769746370448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19070,31,1.11 [0.67-1.83],0.6842916230697342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19121,30,0.73 [0.30-1.76],0.4808104758305578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,19696,31,2.86 [1.00-8.15],0.049683110681939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22715,33,1.28 [0.52-3.15],0.5850697152377402
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19043,29,1.48 [0.58-3.81],0.415345150629509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,22482,31,1.01 [0.30-3.39],0.9878486732266224
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,22588,34,1.63 [0.71-3.73],0.249740560172041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,19121,30,0.96 [0.37-2.48],0.9318344027027858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,19121,30,0.65 [0.36-1.20],0.173018647408207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22785,32,0.72 [0.37-1.42],0.3499716417921182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,22482,31,1.62 [0.78-3.39],0.1959216792612064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,19567,30,5.69 [2.48-13.03],3.923175019044184e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,19121,30,0.74 [0.34-1.64],0.4595159113636193
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,19667,31,0.98 [0.47-2.04],0.9588170216042166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19561,30,0.83 [0.39-1.79],0.6419399921038302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,22160,32,0.85 [0.37-1.94],0.7039677372011213
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19121,30,1.27 [0.60-2.68],0.5352253817435624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19637,31,1.76 [0.72-4.34],0.216186399274881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,22075,32,0.72 [0.37-1.39],0.3287275650351347
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,19289,30,0.69 [0.39-1.21],0.1920582861947158
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,22547,32,4.11 [2.37-7.11],4.44440115023237e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,22547,32,2.65 [1.93-3.63],1.455014888096025e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,22787,33,0.90 [0.51-1.59],0.7074826692492812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,19561,30,1.17 [0.49-2.79],0.7266995017517202
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,22858,34,2.20 [0.89-5.45],0.0869752254134119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,22075,32,1.01 [0.56-1.82],0.9725097066002028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,22478,32,2.05 [0.73-5.74],0.1742448651410066
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,22160,32,1.09 [0.53-2.23],0.8156198520077965
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,19561,30,1.09 [0.52-2.28],0.8274765461431156
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LXN,Latexin,22333,31,1.17 [0.75-1.83],0.4836099959538851
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,22479,32,1.29 [0.57-2.93],0.538044996692171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,22547,32,5.00 [2.04-12.25],0.0004218802719359
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,22367,31,49.76 [26.39-93.81],1.4111160197418262e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,22436,31,0.62 [0.24-1.65],0.3402235708469525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,22075,32,1.70 [1.35-2.13],5.189493867944778e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,22482,31,0.82 [0.57-1.20],0.3082334153915898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,22025,31,0.70 [0.34-1.43],0.323381356535506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,22469,33,0.94 [0.37-2.35],0.8913356236875557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,22075,32,1.84 [1.36-2.50],8.384980842258325e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,19061,30,0.78 [0.51-1.20],0.2620777324996992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19121,30,0.93 [0.65-1.34],0.6967013350283153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19696,31,0.48 [0.09-2.70],0.407318463824991
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,18973,28,0.76 [0.46-1.24],0.2721227670096294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,19255,29,0.71 [0.42-1.20],0.1997980084592894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,19169,30,0.77 [0.28-2.09],0.610026063325749
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22352,31,1.90 [1.40-2.56],3.123773164359521e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,22075,32,0.79 [0.34-1.85],0.5894661179252273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,19121,30,0.96 [0.45-2.01],0.9041835520694887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,19289,30,1.01 [0.67-1.52],0.9616203585918052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,22075,32,0.92 [0.47-1.80],0.8173469626397118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,19667,31,3.20 [1.33-7.72],0.009508597333353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,19561,30,1.38 [0.75-2.54],0.3037794630768989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19169,30,9.20 [2.79-30.35],0.0002712146651706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,19667,31,0.92 [0.52-1.65],0.7847256745210607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",18973,28,0.46 [0.23-0.94],0.0340541228185421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,22689,32,0.81 [0.64-1.02],0.0753794104033971
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,22656,33,1.48 [0.49-4.49],0.4921211018570245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,19070,31,1.10 [0.66-1.82],0.7107347645453119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19061,30,1.85 [0.69-5.01],0.2239856109862684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19070,31,0.50 [0.19-1.29],0.1499585695863598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,19628,31,1.95 [1.11-3.45],0.0211078205230777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19567,30,0.81 [0.46-1.41],0.4509319490052821
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22547,32,0.79 [0.58-1.08],0.1363977564587488
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22075,32,1.03 [0.75-1.41],0.8647557854488208
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22388,31,0.87 [0.65-1.16],0.3346346658842944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,18973,28,1.44 [0.79-2.62],0.2362816929608558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,22547,32,0.69 [0.34-1.42],0.3136153765519845
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,19289,30,0.69 [0.42-1.14],0.1461598306692975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,18973,28,0.81 [0.57-1.15],0.2333927419848155
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,22025,31,1.12 [0.60-2.06],0.7242192419558553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,22588,34,7.24 [3.36-15.59],4.206417341414883e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",19212,29,0.80 [0.52-1.23],0.3151612113690389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,22388,31,0.88 [0.23-3.39],0.8525219001793103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,22622,32,0.95 [0.33-2.73],0.9206413390316956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,22401,31,0.52 [0.19-1.39],0.191816430464005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,22075,32,0.79 [0.55-1.13],0.1894478821323648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAX,Protein max,22025,31,0.78 [0.57-1.07],0.1178341969971728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,22858,34,1.61 [0.98-2.65],0.0624535650353846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,19408,30,0.96 [0.69-1.33],0.8005709022830576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,22650,34,1.78 [0.77-4.09],0.1769416261219858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19637,31,0.91 [0.39-2.12],0.820108750779907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,19118,29,0.88 [0.59-1.32],0.5348730182632174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,22491,34,0.83 [0.41-1.69],0.6070899068279862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,19567,30,0.88 [0.21-3.64],0.8622000224394936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22436,31,1.34 [0.84-2.15],0.2166165929364662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",19549,30,1.21 [0.54-2.75],0.6402781567027866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDK,Midkine,22597,33,0.72 [0.38-1.36],0.3095373858374229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,19121,30,1.31 [0.44-3.91],0.6246485313672805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19169,30,1.02 [0.69-1.49],0.9366082360518546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,22075,32,0.71 [0.47-1.08],0.1145152963298217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,19070,31,0.64 [0.25-1.62],0.3477605592435115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,22580,32,0.98 [0.43-2.24],0.9653550733752324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,19070,31,1.19 [0.49-2.86],0.703484843645013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,22790,34,0.39 [0.08-1.77],0.2215478060533708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,19667,31,0.77 [0.24-2.52],0.6661805528154494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,19255,29,0.34 [0.07-1.58],0.1701522569339519
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,19567,30,0.79 [0.47-1.33],0.370995985719431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,22588,34,0.99 [0.77-1.27],0.9201148671068798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,22580,32,1.14 [0.34-3.75],0.833151585196039
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,22835,33,1.42 [0.44-4.55],0.5554398447854063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,22595,33,0.86 [0.67-1.11],0.2459072836362836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,22645,34,0.41 [0.09-1.78],0.2323798181728304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,22025,31,0.78 [0.47-1.28],0.325133721979805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22547,32,0.83 [0.56-1.22],0.3489672430632015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,22748,33,0.91 [0.54-1.55],0.7377477566427731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,22185,33,1.01 [0.55-1.85],0.9651696714231344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,19121,30,0.67 [0.32-1.40],0.2821040716914582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,19255,29,1.92 [0.62-5.88],0.2552511901158155
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,22858,34,0.82 [0.39-1.70],0.5885065164279226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,22595,33,0.84 [0.40-1.78],0.658348971641971
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,22650,32,0.70 [0.50-0.97],0.0341746282891004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,22547,32,0.85 [0.67-1.08],0.1894817468686696
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,22656,33,1.37 [0.61-3.07],0.4394171929474046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,19121,30,0.99 [0.60-1.64],0.9657785968268908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22547,32,1.06 [0.85-1.34],0.5939186645492557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,22565,33,0.93 [0.60-1.46],0.7648507404836535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,22160,32,2.23 [1.31-3.78],0.0029700203781438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19561,30,0.72 [0.53-0.99],0.0439633931436471
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,19628,31,0.85 [0.59-1.22],0.3804501792770496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,22436,31,0.89 [0.64-1.23],0.4743487264738962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,19118,29,1.28 [0.63-2.64],0.495187421471556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,18973,28,1.00 [0.59-1.70],0.9982570405817792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,22547,32,1.02 [0.72-1.46],0.89299799491517
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,22482,31,0.99 [0.67-1.45],0.9464833919087444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,21721,32,0.97 [0.69-1.36],0.8601861232339574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,22548,31,0.82 [0.46-1.44],0.4822554091681709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,22607,33,1.38 [0.77-2.49],0.2766382431855817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,22025,31,0.32 [0.13-0.82],0.0172932140109682
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,19667,31,0.38 [0.11-1.34],0.131695329850889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,22595,33,1.35 [0.73-2.48],0.3377350492465429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,22144,33,1.61 [0.82-3.15],0.1672820353802764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,22745,32,1.02 [0.66-1.56],0.9358852810956456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,22553,32,1.08 [0.64-1.80],0.7758898603947043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19070,31,1.05 [0.53-2.10],0.8859933680281368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,19121,30,0.78 [0.39-1.57],0.4817466200507945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,19289,30,0.92 [0.40-2.10],0.8450008108499655
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,22553,34,0.94 [0.69-1.29],0.7192463448580526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,19255,29,0.89 [0.52-1.55],0.6903040648269619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,22787,33,1.49 [0.58-3.83],0.4098161742491213
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,19628,31,2.60 [1.61-4.21],9.68901913385079e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,19289,30,0.92 [0.38-2.26],0.8628131833503563
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,18973,28,0.65 [0.20-2.04],0.4571316828102942
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,18973,28,0.88 [0.52-1.48],0.6212878813301342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,22185,33,1.20 [0.81-1.77],0.3628272928817805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,22482,31,0.91 [0.62-1.32],0.6079659479071905
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22650,32,0.75 [0.52-1.09],0.1332066370472713
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,22595,33,1.23 [0.66-2.28],0.5177170633179484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,19518,30,0.87 [0.39-1.95],0.7274744187318873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,19671,31,3.76 [1.41-10.02],0.0081664166921561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,19121,30,0.97 [0.58-1.62],0.9154266432869854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",19070,31,0.83 [0.31-2.22],0.7098567029049582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",19637,31,1.22 [0.60-2.51],0.5806258930892019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",22025,31,0.45 [0.12-1.63],0.2238284764253613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",18945,28,0.88 [0.21-3.77],0.8653503646501324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19637,31,0.99 [0.62-1.59],0.9762442014134888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",19118,29,0.74 [0.18-3.01],0.669630235165523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,22451,31,1.02 [0.56-1.85],0.9552643335096624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,19121,30,0.93 [0.36-2.37],0.8809458999269034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,22498,32,0.84 [0.54-1.30],0.4218104210423172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,22785,32,1.77 [0.89-3.53],0.1061439169778148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,22656,33,0.73 [0.48-1.12],0.1524063076722842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,19358,30,0.78 [0.54-1.12],0.1788123071189747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,22185,33,1.05 [0.57-1.92],0.8874548583679647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,19118,29,1.10 [0.75-1.62],0.6319293387333682
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19628,31,1.01 [0.26-3.84],0.9904980258925458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19289,30,0.80 [0.58-1.11],0.1899277139152161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",19567,30,0.77 [0.51-1.17],0.2203389788921183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,22185,33,1.08 [0.45-2.59],0.8697545833879295
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,19070,31,0.68 [0.34-1.36],0.2700045615597339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,19567,30,0.99 [0.72-1.36],0.9560376992727154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,19561,30,0.79 [0.55-1.14],0.2155954094178278
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,19289,30,0.74 [0.37-1.47],0.3846497881329151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,22025,31,1.19 [0.62-2.26],0.5973452519982256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,22482,31,0.91 [0.78-1.05],0.1960458281860607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,19662,30,0.98 [0.67-1.44],0.9242049885669852
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,18973,28,1.02 [0.46-2.27],0.9612161793988978
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,22160,32,1.08 [0.73-1.61],0.7045987304011548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,19255,29,1.16 [0.36-3.75],0.7995116534976522
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",19667,31,1.74 [1.16-2.62],0.0079787222533697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",19169,30,1.52 [1.21-1.91],0.0003570947560024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19637,31,1.38 [0.93-2.04],0.1106065573705509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,19667,31,0.85 [0.60-1.21],0.3772210262839517
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,19070,31,1.24 [0.67-2.30],0.4992779321771002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,18973,28,1.01 [0.45-2.29],0.9778994162264266
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,19662,30,0.98 [0.72-1.34],0.9220459335018314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19070,31,1.04 [0.45-2.40],0.935630953278836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,19169,30,1.49 [0.93-2.39],0.0969333119068671
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,19169,30,1.61 [1.01-2.55],0.0441642040333469
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,19121,30,0.76 [0.47-1.23],0.2666511874958095
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19121,30,1.09 [0.51-2.33],0.8237311197926654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,19637,31,1.15 [0.49-2.69],0.7459639524234746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,22160,32,0.91 [0.56-1.48],0.6928200918271092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,22595,33,0.81 [0.41-1.57],0.5240916794091368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,19061,30,0.47 [0.17-1.33],0.1532904128996957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,19070,31,0.90 [0.41-1.98],0.7955086202893695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,19255,29,1.35 [0.93-1.98],0.1170338243122045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,22661,32,0.63 [0.33-1.20],0.1622687764557567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,22075,32,0.61 [0.30-1.22],0.1617019747790531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,19070,31,0.77 [0.39-1.51],0.4481073728682658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,19121,30,0.87 [0.64-1.18],0.3623701581596257
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,22331,31,1.22 [0.73-2.06],0.4487208641997993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,19561,30,1.55 [0.93-2.56],0.090386472945344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,22588,34,1.19 [0.73-1.94],0.4730248302463834
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,19079,29,1.38 [0.93-2.05],0.1147360850137472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,19132,30,1.58 [0.89-2.82],0.119304320759275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19255,29,7.52 [2.28-24.83],0.0009338494059526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,22075,32,0.74 [0.37-1.50],0.4053757848849715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,19539,30,1.09 [0.46-2.55],0.8483677448769931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,19628,31,1.77 [0.86-3.63],0.118790547204886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",19637,31,0.88 [0.43-1.79],0.7144560110610915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,22656,33,1.84 [0.59-5.75],0.2970587797777708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,22160,32,1.56 [1.10-2.21],0.0118024125900967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,22650,34,1.03 [0.35-3.09],0.9526905463454494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,22595,33,1.70 [0.56-5.19],0.35162598836635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,22785,32,1.81 [0.77-4.23],0.1703557402197832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,22519,32,0.95 [0.65-1.38],0.7713561722148942
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,22689,32,0.74 [0.55-1.00],0.0524862665311429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,22160,32,1.27 [0.85-1.91],0.2491155370920719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,22513,31,1.42 [0.59-3.39],0.4343527996925148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19567,30,2.65 [1.04-6.74],0.0403886672264841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,22787,33,0.93 [0.31-2.76],0.8930740625645058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,22025,31,0.92 [0.55-1.52],0.731051875092759
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19561,30,1.11 [0.69-1.79],0.6636658424086261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19084,29,1.00 [0.36-2.76],0.9989320191180748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19567,30,0.63 [0.41-0.95],0.0283931918466403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22075,32,0.77 [0.47-1.26],0.2930576970995847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,19070,31,1.76 [1.06-2.91],0.0284088841793683
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,19070,31,0.58 [0.31-1.08],0.0857332624144181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,19118,29,1.53 [0.59-3.96],0.3849615811271645
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,22554,34,2.55 [0.98-6.62],0.0553705204837984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,22656,33,1.26 [0.47-3.42],0.6456471215440178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19118,29,0.68 [0.35-1.33],0.2633631249937564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,19118,29,1.29 [0.51-3.26],0.5874224118090929
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,21946,31,1.15 [0.53-2.49],0.7205299828304921
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,19289,30,1.00 [0.63-1.57],0.9942854329003532
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,22656,33,0.63 [0.31-1.31],0.2149402877360171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,22689,32,2.50 [0.88-7.11],0.0845506456627814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,19561,30,0.79 [0.53-1.20],0.2681731509489043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,19637,31,0.60 [0.12-3.09],0.5393869071499251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,19671,31,0.71 [0.42-1.22],0.2156612148346856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,22835,33,2.53 [0.87-7.34],0.0883049901202761
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,19118,29,1.07 [0.71-1.59],0.7513761703052525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22547,32,0.99 [0.71-1.38],0.9350899572710836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22160,32,0.75 [0.41-1.35],0.3400178007544105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,19169,30,0.82 [0.51-1.34],0.4285043038086887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,19637,31,1.11 [0.55-2.25],0.7788932942563023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,19070,31,1.17 [0.73-1.88],0.5047541819324723
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,19289,30,0.71 [0.29-1.71],0.4408222550974993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,22075,32,2.34 [1.56-3.51],3.827657703925971e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19567,30,0.81 [0.57-1.14],0.2218504832205445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,19070,31,0.78 [0.45-1.36],0.3882754374751219
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,19070,31,1.95 [1.27-2.99],0.002083009186146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,22436,31,1.16 [0.09-15.68],0.9128088030167228
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,19667,31,1.19 [0.42-3.38],0.7482247936256299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,19628,31,2.52 [0.97-6.56],0.0577154583034299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,18774,27,7.26 [2.23-23.60],0.0009920973910629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,22573,34,0.78 [0.36-1.69],0.5339075815336214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,22595,33,0.85 [0.56-1.28],0.4334363756039002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,22075,32,1.26 [0.83-1.91],0.2793522232029334
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,19169,30,1.04 [0.50-2.16],0.9203274362692682
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,19597,30,1.03 [0.65-1.65],0.8880922485068979
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,19121,30,0.46 [0.20-1.08],0.0748371109021029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,19061,30,0.70 [0.29-1.67],0.4185638089950149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,19118,29,0.75 [0.14-4.09],0.7375439047622625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,22622,32,0.67 [0.16-2.82],0.5892501717780718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,19490,30,0.86 [0.51-1.43],0.5525216845722707
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22436,31,1.82 [1.49-2.21],2.1554070267565627e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,18973,28,1.56 [0.93-2.61],0.0914023959584204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19637,31,1.12 [0.70-1.78],0.6335330622430455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,22595,33,1.62 [0.47-5.60],0.4425114867513026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,19070,31,0.73 [0.46-1.14],0.1664321663856898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",22025,31,1.63 [0.90-2.97],0.1073170216105258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",19070,31,0.72 [0.28-1.85],0.4888505497312416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",22025,31,1.68 [1.16-2.44],0.0064351226090035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,22858,34,15.90 [4.80-52.72],6.060461613528759e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,19662,30,3.12 [0.73-13.28],0.12412376959265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,22858,34,2.17 [0.92-5.11],0.0761420953789353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,19325,28,2.65 [1.51-4.67],0.0007126911411854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,22588,34,2.30 [1.02-5.19],0.0457064061590987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,19118,29,1.45 [0.59-3.59],0.4211492827350394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,19118,29,0.81 [0.54-1.23],0.3281342119914575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,19667,31,2.07 [1.06-4.06],0.0342875348352339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,22185,33,0.96 [0.76-1.21],0.7440140794011068
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,22547,32,1.74 [0.92-3.30],0.0887066079308465
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,19070,31,0.63 [0.22-1.82],0.3923683692202923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,22075,32,0.88 [0.57-1.37],0.5717717143978231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,22595,33,1.46 [0.68-3.13],0.3301752830727806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,19662,30,0.92 [0.31-2.76],0.8850809817895843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,22588,34,1.42 [0.62-3.24],0.4055860581448297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,22787,33,0.82 [0.52-1.29],0.3880871092569119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,22588,34,5.57 [2.62-11.84],8.195810143197858e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,19671,31,0.84 [0.57-1.24],0.3806048793452908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,19637,31,1.22 [0.57-2.59],0.6079984507441407
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,22693,34,1.95 [0.69-5.49],0.2086709051624528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,22595,33,2.59 [1.12-6.02],0.0266289429499885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,22160,32,0.79 [0.40-1.53],0.4786431392210646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,19121,30,0.35 [0.09-1.42],0.1405217291715154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,22785,32,0.93 [0.58-1.48],0.7469920231011038
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19667,31,1.05 [0.66-1.68],0.840769857284552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,19628,31,1.20 [0.46-3.17],0.7109880096241386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,22517,32,0.75 [0.53-1.06],0.0982958611644377
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,22656,33,0.77 [0.43-1.36],0.36868936983402
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,22547,32,0.76 [0.31-1.86],0.5443618985789828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,22075,32,0.69 [0.25-1.90],0.4735575505187037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,22588,34,1.25 [0.38-4.10],0.7071199561068007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,22785,32,0.69 [0.17-2.89],0.616035192720354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,22588,34,1.03 [0.76-1.39],0.8501271885292885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,22547,32,1.03 [0.71-1.50],0.8684812625760764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19561,30,0.88 [0.59-1.30],0.519402788035163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,22746,33,0.70 [0.30-1.66],0.4241266273803588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,22835,33,0.82 [0.50-1.33],0.4208206547465495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19169,30,0.87 [0.20-3.76],0.8476562315502987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19070,31,1.07 [0.58-1.98],0.817393775063162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,19531,30,0.67 [0.44-1.02],0.0611258560311447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22482,31,0.51 [0.28-0.96],0.0355412607369842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,22595,33,0.86 [0.47-1.60],0.6415924823088794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,19118,29,0.83 [0.54-1.28],0.3937149399680314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,19070,31,1.97 [1.19-3.25],0.0079707062970367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,19070,31,0.93 [0.34-2.54],0.8887127545344623
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,22025,31,0.99 [0.42-2.34],0.9806700348947328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,19118,29,1.30 [0.39-4.32],0.6712656323965092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,22365,31,0.76 [0.47-1.22],0.2516839393655159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,19637,31,1.90 [0.96-3.77],0.0653852508016613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,21995,31,0.82 [0.44-1.53],0.5332396201233787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,19289,30,1.32 [0.90-1.93],0.1548171922021122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,19567,30,0.94 [0.56-1.55],0.7962018760508217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,22482,31,3.17 [1.40-7.15],0.0054646197768274
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,22595,33,1.47 [0.70-3.08],0.3063453570521303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19289,30,0.84 [0.64-1.11],0.2185368405699287
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,18529,27,0.88 [0.65-1.18],0.3958526448277991
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,22370,34,1.07 [0.65-1.77],0.7914615682362496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,22689,32,1.12 [0.54-2.28],0.765746065766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,22482,31,1.16 [0.70-1.91],0.5606557871762489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,19061,30,1.05 [0.54-2.04],0.8951755478135849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,19628,31,0.90 [0.65-1.25],0.5394478515603116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,19169,30,0.71 [0.41-1.23],0.2218303843798275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,22482,31,0.83 [0.39-1.76],0.6300506232434031
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,19628,31,1.35 [0.25-7.41],0.7289589463542238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,19628,31,0.82 [0.54-1.25],0.3566493299870842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,22622,32,2.35 [0.92-6.01],0.0753115219357002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,22444,32,0.97 [0.63-1.50],0.880758247465956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,22693,34,2.16 [0.52-8.99],0.2905135264978348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,19121,30,0.64 [0.23-1.83],0.4097515036834903
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,19061,30,0.59 [0.24-1.44],0.2475883241786119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,19567,30,0.58 [0.31-1.09],0.0925229514014941
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,19637,31,0.87 [0.50-1.52],0.6335264525528912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19169,30,1.15 [0.69-1.91],0.5998094967552643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,22785,32,0.95 [0.75-1.21],0.7036721528088964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,22472,33,0.61 [0.27-1.39],0.2398598899933268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,19070,31,0.93 [0.52-1.64],0.7909734812878172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,22160,32,0.68 [0.33-1.40],0.2993628168658662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,21995,31,0.88 [0.54-1.41],0.5918814363213787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,22436,31,1.21 [0.94-1.55],0.1376288999160907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19637,31,0.72 [0.46-1.12],0.1444691113626522
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19289,30,0.65 [0.30-1.42],0.2806915171524096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22185,33,1.22 [0.72-2.06],0.4661519155304504
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,19169,30,1.53 [0.84-2.80],0.1640231294407805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,18935,28,0.64 [0.29-1.40],0.2629101373275145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,22025,31,0.61 [0.33-1.13],0.1157578802150562
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,19118,29,1.14 [0.52-2.48],0.7419884650506132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,19464,30,1.40 [0.44-4.41],0.5676164638407789
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,19628,31,1.53 [0.65-3.60],0.3362930845308118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,19070,31,0.87 [0.50-1.52],0.6293223936495718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,22729,34,2.36 [0.72-7.68],0.1546402821397287
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,22595,33,0.84 [0.28-2.58],0.7627468949142122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,22160,32,1.20 [0.61-2.36],0.5990211453839249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,19289,30,0.71 [0.40-1.24],0.2280188616994278
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,22595,33,0.91 [0.51-1.62],0.7432600766098123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,22547,32,1.95 [1.66-2.30],1.6334354362439205e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,19255,29,1.04 [0.48-2.27],0.913339334659577
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,18973,28,1.31 [0.41-4.17],0.6481430092879052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,22025,31,1.42 [0.78-2.57],0.2513100377822168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19567,30,1.11 [0.36-3.40],0.8524150334096466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,19061,30,0.81 [0.49-1.36],0.4287762780949422
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19216,29,2.08 [1.14-3.79],0.0170418071559909
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,19637,31,0.83 [0.51-1.36],0.4675140433634176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,22765,33,2.15 [0.79-5.86],0.1335041492856391
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,19637,31,2.28 [0.82-6.34],0.1140022025381428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,22588,34,3.24 [1.55-6.77],0.0017845151807443
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,19567,30,0.48 [0.14-1.69],0.2529835035598209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,19567,30,2.98 [1.12-7.95],0.0292692707612533
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,19561,30,1.82 [0.91-3.65],0.089344663504009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,18973,28,0.77 [0.37-1.61],0.4827525148677463
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,19561,30,0.41 [0.16-1.04],0.0590946020083784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,22858,34,0.89 [0.41-1.91],0.7605911695164544
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,19567,30,1.04 [0.66-1.65],0.8706884596074013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,19667,31,0.83 [0.58-1.19],0.3120405013174488
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,22755,33,3.45 [2.59-4.60],3.96781875060392e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,22482,31,2.13 [0.82-5.56],0.1225371229239273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,22785,32,0.93 [0.54-1.59],0.7883651739728081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,22588,34,1.03 [0.65-1.61],0.906206035193494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,18973,28,0.57 [0.23-1.41],0.2250663454579201
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",18973,28,0.42 [0.15-1.22],0.1102581056721858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19070,31,0.77 [0.38-1.56],0.4634477266347147
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19255,29,0.81 [0.58-1.13],0.2216884632064999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,22858,34,0.78 [0.52-1.18],0.2445769151004327
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,22689,32,0.68 [0.48-0.95],0.0258242904423146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,22075,32,0.72 [0.24-2.18],0.5669948785728127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,22588,34,1.85 [0.67-5.11],0.2340605334081624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,22858,34,1.14 [0.48-2.73],0.7642915816787959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,18973,28,0.76 [0.28-2.06],0.5829384829663539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,19255,29,1.49 [0.54-4.06],0.4413364391351242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,19662,30,0.95 [0.53-1.71],0.8604516181972071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,18973,28,0.81 [0.41-1.58],0.5335283560823556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,19637,31,0.88 [0.66-1.17],0.3785603836533847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,22689,32,0.79 [0.61-1.02],0.06771203066868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22075,32,0.90 [0.47-1.73],0.7482245704931174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,19121,30,0.56 [0.24-1.33],0.1912149778660724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,18973,28,1.30 [0.89-1.90],0.1736707056773924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,19070,31,1.07 [0.62-1.86],0.8000051157475588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19118,29,1.71 [0.95-3.07],0.0730508959142768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,22858,34,1.12 [0.29-4.33],0.8683931474092437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,22595,33,1.05 [0.62-1.78],0.8490823882554859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,22595,33,1.69 [0.63-4.52],0.2931099064126464
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,19169,30,1.31 [0.49-3.54],0.5894846638785629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,19255,29,0.60 [0.17-2.08],0.4219465043335975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,19671,31,1.42 [0.38-5.27],0.6038716174888707
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,19118,29,1.12 [0.84-1.50],0.4427195439439029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,19555,31,0.93 [0.66-1.33],0.7029498879593363
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,22025,31,0.95 [0.53-1.68],0.8474963838972517
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,18973,28,0.72 [0.33-1.59],0.4235993407525081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,19121,30,0.67 [0.33-1.38],0.2763639661300504
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22442,31,1.13 [0.75-1.71],0.5646418218336116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,19671,31,1.21 [0.74-1.99],0.4378119279862249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19667,31,0.94 [0.50-1.77],0.845194253173647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,22835,33,1.37 [0.43-4.36],0.5977442871489891
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,22751,34,1.14 [0.56-2.29],0.7199246788173599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19437,30,1.30 [0.41-4.10],0.6497411359250058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,19070,31,1.26 [0.82-1.93],0.2982957036416823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,19121,30,1.16 [0.70-1.92],0.556478547750614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,19118,29,1.20 [0.93-1.54],0.1545093023108442
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,19637,31,0.90 [0.66-1.21],0.4830733624607433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,19567,30,1.04 [0.54-2.00],0.911580018174232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,18973,28,0.94 [0.62-1.41],0.755150723829894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22436,31,2.25 [0.78-6.54],0.1345717379808028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19255,29,1.97 [0.84-4.62],0.1173411939540075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,19671,31,1.70 [0.43-6.77],0.4540500654305817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PI3,Elafin,22289,33,0.94 [0.52-1.69],0.8321800181390107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19637,31,1.12 [0.72-1.73],0.6118853960354546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,22306,31,0.98 [0.38-2.54],0.9664779242915652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22547,32,1.94 [1.26-3.00],0.0028493529412266
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22595,33,3.74 [1.42-9.84],0.0075624816170431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19118,29,1.43 [0.91-2.26],0.1244472560992329
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,22595,33,0.96 [0.46-2.00],0.91332390807472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,22588,34,0.96 [0.57-1.62],0.8654080000883834
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19255,29,0.96 [0.57-1.61],0.871997202348637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,18935,28,0.87 [0.52-1.45],0.5814163638034517
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,19667,31,0.98 [0.26-3.69],0.9725794219462836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,19070,31,1.04 [0.58-1.86],0.8919627428513094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,22616,32,1.18 [0.76-1.82],0.4704527132442148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,19289,30,0.57 [0.35-0.94],0.0258383155389267
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,22436,31,0.77 [0.47-1.28],0.3133210398620731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,22656,33,3.71 [1.24-11.07],0.0189294188392698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,22819,33,1.01 [0.49-2.09],0.9692559286320176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",22512,32,1.18 [0.72-1.92],0.5070229795893075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,22689,32,0.66 [0.46-0.95],0.024276304794457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,22595,33,1.97 [0.73-5.32],0.1829614829377576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,22790,34,1.06 [0.57-1.96],0.8594443525338384
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,22595,33,2.04 [1.31-3.19],0.0016900675709028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,22437,31,2.60 [0.82-8.25],0.104211093778052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",19628,31,0.95 [0.54-1.67],0.8693482792686876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19118,29,1.28 [0.68-2.40],0.4421467781998695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19628,31,0.85 [0.60-1.21],0.3669063360252046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,19628,31,1.02 [0.62-1.67],0.9515075283498806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,19177,29,0.35 [0.08-1.60],0.1758243740872008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,22025,31,0.39 [0.13-1.18],0.0954187535653112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,22588,34,1.45 [0.75-2.81],0.2700474303906289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,22588,34,0.93 [0.59-1.46],0.7612395812527508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,19598,31,0.88 [0.49-1.58],0.6808060797713764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,22771,34,0.98 [0.40-2.37],0.9581301237620948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,22075,32,1.39 [0.72-2.68],0.3339244817629517
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,19628,31,0.85 [0.23-3.13],0.8054363120124056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,22547,32,0.77 [0.53-1.12],0.172564536611176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,22757,34,3.16 [0.95-10.50],0.0609856478503473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,22522,34,0.97 [0.51-1.87],0.9366746165732194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22483,34,1.04 [0.88-1.24],0.6190605430861794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,19070,31,0.80 [0.47-1.38],0.4295914523796211
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,19070,31,0.96 [0.54-1.72],0.8899348525022928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,19121,30,2.09 [1.46-2.97],4.64136713358968e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,21986,31,0.84 [0.65-1.09],0.1917501903127116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,19671,31,1.01 [0.57-1.79],0.975304938712196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,19628,31,0.92 [0.58-1.45],0.7164464480698396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,22580,32,1.00 [0.90-1.12],0.9417566038668432
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,19169,30,0.82 [0.42-1.60],0.5662712009512548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,19061,30,1.58 [0.90-2.77],0.1126884256863182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22160,32,0.63 [0.42-0.94],0.024140107536878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,22482,31,4.02 [0.51-31.80],0.1873371767267804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,22656,33,1.02 [0.33-3.12],0.9730099425361288
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,19118,29,1.13 [0.54-2.39],0.7467632744692374
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,19118,29,0.92 [0.27-3.10],0.897658123077179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22482,31,2.61 [1.80-3.78],3.7534525295386425e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,19169,30,1.08 [0.64-1.82],0.7680383187524686
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,19671,31,0.48 [0.19-1.27],0.1387759723273644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,22185,33,1.43 [0.59-3.47],0.4246742430646455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,22689,32,0.78 [0.56-1.09],0.1475360228622182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,19662,30,0.32 [0.12-0.84],0.0204149667767049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,19551,31,0.72 [0.49-1.08],0.1124997042279161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,22785,32,0.85 [0.43-1.68],0.6456663476163138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,22594,32,0.91 [0.66-1.27],0.5835556536916973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,19289,30,0.97 [0.55-1.69],0.9026385985834154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19662,30,0.88 [0.49-1.58],0.6644151995422227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,19118,29,1.34 [0.54-3.36],0.5294285719507712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,22075,32,0.44 [0.14-1.40],0.1644611446097814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,19118,29,1.26 [0.83-1.90],0.2810069850159595
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,19667,31,0.70 [0.35-1.37],0.296567025299696
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,22482,31,1.04 [0.62-1.75],0.8734069998102215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19561,30,0.71 [0.45-1.10],0.1272459985283244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22656,33,0.82 [0.59-1.14],0.2301618527454207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19289,30,0.54 [0.27-1.08],0.0812459699650813
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19637,31,0.84 [0.53-1.32],0.4501128127056761
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19637,31,1.20 [0.51-2.81],0.6788498344270915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,22588,34,1.04 [0.71-1.52],0.8394459217484086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,22835,33,0.99 [0.71-1.37],0.9395389439225414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19567,30,0.87 [0.64-1.19],0.3801235234481654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,22436,31,0.53 [0.24-1.18],0.1216746813558307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,19121,30,0.75 [0.41-1.40],0.3696047188157836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,22574,33,0.96 [0.71-1.30],0.8056618133632756
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,22075,32,1.85 [1.48-2.32],9.527011950460062e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,18973,28,1.20 [0.32-4.61],0.785625433104576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,19662,30,1.07 [0.46-2.48],0.8743484434000034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,19561,30,0.45 [0.12-1.70],0.2418192403421171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,22725,33,2.21 [1.15-4.22],0.0168617278057286
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,21971,30,1.09 [0.76-1.57],0.6276097725413503
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,19332,31,1.34 [0.82-2.21],0.2465087546853823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22160,32,0.87 [0.56-1.36],0.5462832991574743
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",22835,33,0.74 [0.49-1.11],0.1472112546042168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,22787,33,0.79 [0.47-1.34],0.3845461984344773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,22160,32,0.80 [0.48-1.31],0.370541803489718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,22580,32,2.80 [0.82-9.61],0.100968182552712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,19662,30,1.10 [0.57-2.12],0.7841951574114774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,19662,30,0.46 [0.25-0.86],0.0148807234684855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22160,32,0.96 [0.53-1.73],0.8932441799049984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19121,30,1.32 [0.50-3.45],0.5751300874944345
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22588,34,0.89 [0.62-1.27],0.5165873393962048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19592,31,0.93 [0.62-1.41],0.7440196639196209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,22160,32,1.36 [0.78-2.36],0.2721819941761664
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,19070,31,0.35 [0.11-1.08],0.0671904555003837
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,19255,29,0.81 [0.61-1.07],0.139462322106299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22075,32,1.42 [0.92-2.20],0.1153899676119816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,22785,32,1.04 [0.69-1.59],0.836903169243091
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,19628,31,1.64 [0.92-2.95],0.0962978939678285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,22613,34,0.82 [0.47-1.42],0.4792045084844035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,19070,31,1.22 [0.59-2.53],0.5921971751424158
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,22547,32,1.10 [0.69-1.75],0.6947537658824456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,19696,31,0.31 [0.08-1.21],0.0922870685632498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,19117,29,0.88 [0.52-1.50],0.6374398373068368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,19118,29,1.00 [0.47-2.11],0.9918593296668072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,19169,30,2.60 [1.18-5.76],0.0181625046129301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,22650,34,0.71 [0.38-1.31],0.2701139211460878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,19118,29,0.57 [0.17-1.88],0.3565642004956109
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,22521,34,0.58 [0.27-1.26],0.1685583549342597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,19628,31,0.75 [0.30-1.88],0.5361440759117937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,22504,31,1.10 [0.51-2.40],0.8023789514854489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22025,31,0.80 [0.61-1.05],0.1083335041309794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,22787,33,2.12 [0.65-6.91],0.2145521338889784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,22000,32,0.94 [0.48-1.83],0.8467352192998344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,19289,30,1.07 [0.35-3.29],0.9115170967683732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,19470,28,2.49 [1.33-4.66],0.0044056498171755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,19567,30,0.87 [0.43-1.76],0.6946819348940063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,19567,30,1.15 [0.98-1.34],0.0879680572874932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,22436,31,0.99 [0.75-1.30],0.9388374994199188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,22547,32,1.72 [1.35-2.19],1.1036931215979848e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,22075,32,0.86 [0.41-1.78],0.6825937735224857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,18973,28,0.44 [0.13-1.54],0.1991096749108162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,19637,31,1.57 [0.87-2.84],0.1344946594665282
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,19121,30,0.81 [0.39-1.69],0.5815247387160438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,22482,31,0.96 [0.54-1.69],0.8818437807352684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,22405,30,1.51 [0.65-3.47],0.3363127121043456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,22324,31,1.82 [0.79-4.17],0.1567391228176044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,22547,32,1.34 [0.75-2.38],0.3187221008477217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,19118,29,1.48 [0.88-2.47],0.1377488388870828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,22547,32,0.84 [0.61-1.16],0.2802104849886482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,22075,32,0.50 [0.25-0.97],0.0405377772334313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18567,28,0.78 [0.57-1.08],0.1304544091513427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22025,31,0.42 [0.15-1.22],0.1126179610308587
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,22391,34,3.39 [1.75-6.59],0.0003026050144741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,18968,29,1.22 [0.64-2.31],0.5415224206312833
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,19667,31,1.04 [0.68-1.59],0.8627643362117523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,19121,30,0.85 [0.53-1.34],0.4777264313413353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22547,32,0.48 [0.15-1.51],0.2105347133956775
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,22025,31,0.56 [0.24-1.27],0.1651112942566139
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,22185,33,1.46 [0.81-2.63],0.2123411142053834
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,19118,29,1.22 [0.69-2.18],0.4941815519893014
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22436,31,1.24 [0.85-1.83],0.2671704344772126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22650,32,0.76 [0.55-1.04],0.0854862898554113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19080,29,0.64 [0.21-1.88],0.4136899680063685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,19667,31,0.46 [0.14-1.53],0.2036004094909477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,19662,30,17.70 [9.37-33.44],8.621451171609875e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,22858,34,1.66 [0.58-4.76],0.3496246747187019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,19567,30,1.44 [0.73-2.85],0.2935015134284895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19567,30,1.97 [0.62-6.22],0.2471658701934674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,22510,32,6.18 [2.02-18.86],0.0013801612161413
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22357,31,2.52 [0.99-6.44],0.0537705813372604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,19628,31,1.45 [0.57-3.73],0.4368402470422774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,22858,34,8.96 [2.72-29.51],0.0003112536999477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19667,31,1.18 [0.42-3.36],0.7518860002018782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19255,29,0.76 [0.42-1.38],0.3704176304916791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,21935,31,1.42 [0.85-2.38],0.1849902714849723
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,19289,30,0.69 [0.27-1.75],0.4339106589471755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,22547,32,2.01 [0.94-4.31],0.0711686378893523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,22675,33,0.87 [0.67-1.13],0.311339840762129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,22785,32,1.55 [0.70-3.44],0.2840178504275794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,19561,30,1.01 [0.55-1.86],0.9785829699702724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,22025,31,1.35 [0.81-2.24],0.2557038751442053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,19169,30,0.97 [0.41-2.27],0.9403740024294814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,19070,31,0.82 [0.56-1.20],0.2998114359820006
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,19696,31,0.93 [0.54-1.61],0.7935806483769501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,22489,34,1.32 [0.67-2.62],0.4220515118479222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,22628,33,3.61 [1.58-8.24],0.0023126926829678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,19291,30,1.13 [0.57-2.23],0.734932160482622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,19667,31,0.98 [0.51-1.85],0.940953294430347
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,19667,31,0.89 [0.65-1.23],0.4881369059447077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,19667,31,0.80 [0.54-1.20],0.2815064756172467
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,19561,30,0.57 [0.31-1.04],0.0656770209083259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,19070,31,0.70 [0.40-1.22],0.2040735722390238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,22160,32,0.59 [0.35-0.99],0.0437115727940416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,19070,31,0.76 [0.43-1.33],0.3338448850611312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19061,30,1.19 [0.72-1.97],0.5001665242583013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,19561,30,0.80 [0.32-2.04],0.6457936467122586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,22547,32,0.64 [0.32-1.27],0.1994450665780952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,22025,31,0.81 [0.40-1.66],0.568827906236564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,19255,29,0.92 [0.57-1.46],0.7079529808367684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,22075,32,0.60 [0.31-1.18],0.1377795087304675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,22160,32,1.02 [0.61-1.71],0.9412338096948764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,19121,30,1.03 [0.64-1.66],0.910139707893165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,22075,32,0.61 [0.30-1.25],0.1747690947516673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,19289,30,0.81 [0.38-1.73],0.5809159426398314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,19118,29,0.90 [0.27-2.95],0.8567297092635806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,19561,30,1.65 [1.09-2.52],0.0185106030144196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,19169,30,1.15 [0.60-2.19],0.6667491073397127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,19061,30,1.54 [0.61-3.90],0.357785484803177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,22075,32,1.19 [0.69-2.06],0.5389710956143543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,19118,29,1.15 [0.76-1.72],0.507074821786008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,19289,30,0.73 [0.36-1.51],0.3960575687153627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,22075,32,0.47 [0.15-1.51],0.2040772310480093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,22693,34,0.65 [0.33-1.28],0.21323901145036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,22025,31,0.76 [0.49-1.19],0.2364720312737666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,18973,28,1.23 [0.57-2.67],0.5980269698434524
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,22075,32,1.62 [1.19-2.20],0.0020488833120028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,19637,31,1.94 [1.03-3.65],0.0412067259185082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,22047,31,1.80 [1.02-3.20],0.0430671682351274
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,19637,31,0.81 [0.51-1.29],0.3668480847350198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,19070,31,1.62 [1.07-2.46],0.0223570023447815
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,18973,28,0.65 [0.29-1.48],0.3050788040207163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,19121,30,0.73 [0.37-1.45],0.3669903709064795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,22482,31,1.30 [0.87-1.96],0.2040747138283349
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,22482,31,1.50 [0.91-2.46],0.1091175778092098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,19567,30,0.80 [0.43-1.51],0.4986743645488968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,19118,29,0.80 [0.41-1.56],0.510853631724968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,19169,30,0.93 [0.66-1.31],0.6719923787884177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,19561,30,1.46 [0.93-2.27],0.0978648381555356
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,22185,33,1.61 [1.15-2.25],0.005061425607414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19169,30,1.50 [0.26-8.75],0.6538939330405492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,19637,31,1.09 [0.64-1.87],0.7497888418118352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,22430,34,1.15 [0.64-2.08],0.6431500349692009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,22858,34,1.05 [0.62-1.77],0.8571740270484741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,22858,34,1.14 [0.71-1.83],0.597898965168961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,19561,30,0.86 [0.35-2.11],0.7499773006464672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,22622,32,1.12 [0.59-2.13],0.7274996600509429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,19118,29,0.77 [0.35-1.71],0.5211349165208838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,22595,33,5.37 [2.27-12.73],0.00013429809774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REN,Renin,22588,34,0.93 [0.61-1.42],0.7511021866292007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,19118,29,0.70 [0.26-1.90],0.4841962447275234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,18973,28,1.39 [0.64-3.03],0.4017763821835739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22482,31,0.61 [0.28-1.32],0.2067453631571515
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RETN,Resistin,22521,34,1.61 [0.84-3.10],0.1542293217477947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",19070,31,0.82 [0.37-1.83],0.6264732949839924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,19561,30,0.62 [0.11-3.63],0.5954832764903255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,19637,31,0.80 [0.50-1.26],0.3258298419341148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19289,30,0.98 [0.56-1.70],0.9347260410579374
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,22785,32,0.95 [0.34-2.63],0.9181653473740252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,22785,32,1.56 [0.48-5.09],0.4619803533616075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,19637,31,0.83 [0.46-1.51],0.5409416132626179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,22160,32,0.57 [0.27-1.18],0.1265560479769248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,22280,31,0.85 [0.66-1.11],0.2383861733741501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,19118,29,0.87 [0.39-1.97],0.7453545644657346
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19255,29,1.81 [0.99-3.31],0.0554620728391651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,22715,33,0.91 [0.55-1.53],0.7338007251794105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,19667,31,0.79 [0.56-1.11],0.1720097213842089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19070,31,0.81 [0.45-1.47],0.4913952990703906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,19637,31,1.23 [0.86-1.75],0.251272001339663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,19218,28,1.12 [0.87-1.43],0.3780642650259093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,19671,31,1.81 [0.70-4.70],0.2234738777750981
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,19169,30,1.26 [0.68-2.36],0.4643662696522238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,22486,34,0.87 [0.65-1.17],0.3571891005140709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,19004,30,1.28 [0.37-4.37],0.6977912811637506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,19515,30,2.23 [1.43-3.46],0.0003814279755415
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,19637,31,0.88 [0.42-1.84],0.7364761129126758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,22757,33,2.96 [1.69-5.19],0.0001427330288216
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,19169,30,2.24 [0.98-5.10],0.0551538271845188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,19118,29,1.53 [0.84-2.79],0.167611295415543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,19118,29,1.13 [0.47-2.74],0.78692482024433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,19289,30,0.82 [0.45-1.49],0.507591939120137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,22075,32,0.90 [0.56-1.46],0.6797999432299534
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,19289,30,0.49 [0.19-1.26],0.1363953898206246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,19169,30,0.76 [0.47-1.21],0.2424964035332668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,22622,32,3.85 [1.46-10.16],0.0064932899678408
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,22785,32,1.07 [0.28-4.09],0.9196696720779104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,19169,30,3.19 [0.46-21.94],0.2392643534136866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22588,34,6.37 [2.57-15.79],6.354687851884253e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,22482,31,0.59 [0.26-1.34],0.2058944318639248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,19118,29,1.61 [0.68-3.83],0.2805836978930535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,19289,30,0.57 [0.31-1.04],0.0649478282056962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,19121,30,1.18 [0.55-2.49],0.6727547945299706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,19169,30,2.48 [1.59-3.88],6.78370836694609e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,19070,31,0.82 [0.33-2.05],0.6738130094629023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,19121,30,0.88 [0.67-1.17],0.3895395866439958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,22075,32,1.49 [1.08-2.04],0.0151637774021172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22075,32,1.21 [0.76-1.92],0.4154794591269822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,19061,30,1.09 [0.76-1.57],0.6451157192596794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,22436,31,1.25 [0.50-3.12],0.6266583832003709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,22787,33,2.87 [1.04-7.92],0.0425045092863276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,22482,31,0.85 [0.28-2.63],0.7839420614365715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,19070,31,0.88 [0.43-1.81],0.7270328544571325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19637,31,1.00 [0.69-1.46],0.98564729051324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,22787,33,1.24 [0.54-2.83],0.6122189332769608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,22075,32,0.81 [0.56-1.15],0.2373639962617318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,22785,32,0.82 [0.50-1.35],0.4392927771809928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,19070,31,1.17 [0.48-2.82],0.7324442108601271
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,22408,34,1.07 [0.58-1.98],0.8218632145454339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,22280,31,1.18 [0.78-1.77],0.4305690877525819
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,19118,29,1.95 [0.95-3.99],0.0678125564541055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,19637,31,0.94 [0.50-1.77],0.8509060842014032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,21995,31,0.93 [0.55-1.56],0.7761087664020063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,19561,30,1.37 [0.86-2.19],0.1867890020172715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,22656,33,0.71 [0.42-1.22],0.215573608320591
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,19637,31,1.20 [0.56-2.55],0.6419214903864725
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,22185,33,0.90 [0.50-1.63],0.7370019946561126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,19696,31,1.05 [0.38-2.93],0.9188682452333028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,19637,31,2.38 [1.44-3.92],0.0007102107727326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,19061,30,0.52 [0.25-1.10],0.0856751726660936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,22547,32,0.89 [0.57-1.38],0.5996147014964284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,19289,30,0.90 [0.54-1.50],0.680295112465105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,19591,30,0.80 [0.58-1.09],0.1589564131825441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,19070,31,0.30 [0.04-2.15],0.2327210757898214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,19070,31,0.45 [0.17-1.17],0.1006386679938685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,19289,30,0.93 [0.54-1.60],0.7938961599174452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,19637,31,0.46 [0.11-1.99],0.2967372851788455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,19624,30,0.56 [0.19-1.63],0.2910556087799142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,22482,31,1.11 [0.77-1.60],0.5701737895128538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,22785,32,1.48 [0.52-4.28],0.4641704425929639
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,22025,31,0.52 [0.23-1.21],0.1296108563413328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,22013,30,2.34 [0.92-5.94],0.0741282735391237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,22858,34,0.96 [0.47-1.97],0.9088163957377648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,22785,32,2.69 [0.98-7.36],0.0538798040676212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,22674,33,1.61 [0.62-4.17],0.3236584363795963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,22622,32,1.20 [0.47-3.04],0.7053797797999699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,22615,31,1.32 [0.72-2.42],0.3663229900425609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,19070,31,0.67 [0.19-2.36],0.5286427228372362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,19255,29,1.79 [0.43-7.55],0.4256461837940605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,22650,32,0.90 [0.61-1.32],0.5762428005989032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,22160,32,0.98 [0.48-1.99],0.9555218009767752
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,19061,30,0.86 [0.51-1.44],0.562607702383827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,22715,33,1.75 [0.98-3.13],0.0583377132920255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,19061,30,1.52 [0.96-2.39],0.0712379589559226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,19121,30,0.83 [0.23-2.96],0.7724581920328076
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,19121,30,1.17 [0.51-2.67],0.7050225187383619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,19061,30,1.32 [0.74-2.35],0.3415169243269574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,19169,30,1.47 [0.65-3.34],0.3525118994961659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,22075,32,0.48 [0.26-0.91],0.023899015096561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,19094,30,1.19 [0.59-2.41],0.6238965294446036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,19667,31,1.54 [0.45-5.27],0.4950292629655106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,19169,30,1.14 [0.82-1.59],0.447138330521447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,22547,32,0.97 [0.56-1.70],0.9195123083503692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCT,Secretin,19121,30,0.81 [0.37-1.77],0.5934316749738646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,22588,34,2.73 [1.85-4.01],3.508432911824016e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,22588,34,0.47 [0.25-0.89],0.0200898328624739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,19561,30,0.95 [0.69-1.29],0.7320101590717358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,19567,30,0.91 [0.53-1.54],0.7175603618129395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,19255,29,3.94 [3.05-5.09],8.013223088997459e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,19169,30,0.83 [0.53-1.31],0.4284033734580391
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,19169,30,1.31 [0.57-3.01],0.5312605378175341
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,22858,34,2.09 [1.11-3.92],0.0215012348526849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,19696,31,0.37 [0.08-1.76],0.2117258387360894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,19696,31,7.76 [4.42-13.64],1.0076496310350137e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,22650,34,0.82 [0.48-1.40],0.462256378328289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,22547,32,1.03 [0.33-3.23],0.9540322203536848
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,22588,34,1.12 [0.35-3.61],0.8484007883503866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,19255,29,2.92 [1.58-5.38],0.0005911398984256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,22482,31,1.05 [0.33-3.29],0.9351596263471136
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,22785,32,2.49 [0.86-7.15],0.0910886060155689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,19118,29,0.77 [0.18-3.24],0.7185948561503541
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,22790,34,5.96 [4.25-8.35],3.778464757697016e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,19637,31,0.92 [0.57-1.49],0.7353946264468949
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,19289,30,0.48 [0.18-1.28],0.1431236952554773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,19587,31,1.93 [0.79-4.71],0.1465410893242074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,22482,31,1.96 [0.87-4.44],0.10573019343684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,19308,30,4.25 [0.07-275.64],0.4962804483851979
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,22858,34,1.00 [0.47-2.12],0.9921230923504354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,21945,34,0.81 [0.58-1.14],0.2252694553506227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,19615,30,1.21 [0.12-12.64],0.8732705366422773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,19317,29,0.36 [0.09-1.50],0.1596922979579056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,19391,30,0.82 [0.50-1.35],0.4387524309430246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,19696,31,0.48 [0.06-3.79],0.4862122525302458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,19696,31,4.89 [1.18-20.22],0.0282301723100944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,22351,31,0.82 [0.52-1.29],0.3878587996632927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,22523,32,0.81 [0.56-1.16],0.2496681135247911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,22185,33,1.01 [0.54-1.88],0.984559917090518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,22714,32,0.66 [0.39-1.15],0.1421818194431392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,22835,33,1.60 [1.18-2.17],0.0026802955659272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,22436,31,1.05 [0.40-2.75],0.9199749632022146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,19652,31,0.67 [0.22-2.03],0.4742456155896821
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,19652,31,0.44 [0.13-1.50],0.1877436129992479
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,22858,34,0.81 [0.52-1.25],0.3336663481120374
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,19667,31,0.61 [0.35-1.07],0.0871776773630182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,19394,31,0.56 [0.15-2.14],0.398079614823085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,19318,31,0.60 [0.18-2.01],0.4059157008588284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,19652,31,0.76 [0.12-4.87],0.7764315307288225
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,19289,30,0.76 [0.58-1.00],0.0463484440592558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,19212,29,0.62 [0.18-2.07],0.4335854643011273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,19567,30,1.14 [0.62-2.08],0.6766173128828767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22025,31,0.80 [0.48-1.35],0.4090520740188247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,22374,31,2.73 [1.29-5.78],0.0084050146262294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,19121,30,1.12 [0.37-3.43],0.8421575145567797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,22656,33,1.64 [0.55-4.91],0.3762485474572424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,22482,31,1.62 [0.45-5.78],0.4601824943643945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,22482,31,0.98 [0.63-1.50],0.909624843338842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,22370,31,0.94 [0.44-2.00],0.8792529303167798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,19255,29,2.15 [0.92-4.99],0.0762398508092636
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,22075,32,1.01 [0.59-1.74],0.9635110182701648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,22075,32,1.93 [1.20-3.12],0.0071347636131927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,22588,34,1.00 [0.63-1.59],0.9927400329645916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,19314,30,0.90 [0.47-1.73],0.7592085558739002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,22075,32,0.75 [0.54-1.04],0.0803046132354526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,22547,32,1.03 [0.60-1.77],0.9090907990763966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19061,30,0.86 [0.45-1.65],0.6543798275394468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,19567,30,0.53 [0.21-1.34],0.1815002531587908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,19184,30,0.90 [0.60-1.35],0.6030497828560029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,19628,31,0.83 [0.50-1.39],0.4796558533120499
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,19671,31,1.25 [0.66-2.40],0.4938487908100584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,18973,28,0.73 [0.51-1.05],0.0932374354425879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,19031,31,0.58 [0.30-1.12],0.10403337675787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,19118,29,1.36 [0.72-2.58],0.3471287880517104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,19662,30,2.19 [0.88-5.46],0.0933863602748645
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",22650,32,0.72 [0.50-1.04],0.0765862383265418
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,19289,30,0.52 [0.17-1.55],0.2402676268654229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,22620,33,0.79 [0.40-1.55],0.4893784861144664
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,22689,32,1.78 [0.90-3.53],0.0979710074896726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,22547,32,20.00 [12.00-33.33],1.3454528826751825e-30
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,22025,31,0.63 [0.35-1.14],0.1258410315126082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,22595,33,1.51 [1.04-2.19],0.0298009297921011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,22787,33,4.77 [3.28-6.95],3.238984972967007e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,22588,34,2.29 [0.82-6.36],0.1122290152506936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,19169,30,3.32 [1.64-6.71],0.0008473246686177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,22754,33,0.48 [0.18-1.33],0.1583787792688545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,19169,30,1.27 [0.54-3.00],0.5863886686031267
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22638,33,0.86 [0.51-1.44],0.5719681830750263
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,22546,32,1.65 [0.84-3.25],0.1490834664269354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,19118,29,1.36 [1.07-1.73],0.0130649533161652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,22482,31,0.85 [0.59-1.21],0.3665688988539254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22025,31,0.49 [0.23-1.06],0.0704117733111585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,22160,32,1.45 [0.84-2.50],0.1800628357359482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,22388,31,0.76 [0.49-1.19],0.2334337050415957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,22689,32,0.72 [0.53-0.97],0.0310509675378804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,19070,31,0.56 [0.20-1.62],0.2859632425558809
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,19637,31,0.75 [0.54-1.05],0.0944870545453278
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,22160,32,1.78 [1.03-3.08],0.0403216795827924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,22075,32,4.53 [3.45-5.95],1.7110146739987608e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,22547,32,1.24 [0.73-2.13],0.4244864583029238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,22075,32,2.31 [1.40-3.81],0.0010455854816386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,19070,31,0.64 [0.16-2.59],0.5344785395259382
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,19561,30,0.51 [0.20-1.32],0.1653212247483662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,22025,31,0.98 [0.57-1.71],0.95136479006015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,19121,30,0.82 [0.38-1.74],0.6002335715873677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,22025,31,0.61 [0.35-1.08],0.0916356822092396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,18973,28,1.14 [0.67-1.93],0.6339261153401494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,18973,28,1.06 [0.53-2.13],0.8628803473624731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,22025,31,0.76 [0.28-2.07],0.5869962619336251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,22547,32,0.97 [0.53-1.76],0.91721813509639
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,19121,30,0.65 [0.32-1.33],0.2395674110801315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,19662,30,2.00 [1.03-3.88],0.0394527042797081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,19070,31,1.09 [0.72-1.64],0.6924534995478602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19255,29,0.78 [0.50-1.20],0.2542516412933001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19567,30,1.17 [0.67-2.06],0.5818501457600357
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",18973,28,0.48 [0.20-1.17],0.1058004965208028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,22025,31,0.84 [0.43-1.62],0.5937587919872778
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,19118,29,1.47 [0.49-4.44],0.4949160410640486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,22787,33,1.65 [0.74-3.70],0.2246832685119291
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,22185,33,1.36 [0.58-3.21],0.4779235275043135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,19289,30,0.85 [0.50-1.44],0.5480018073818007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,19567,30,0.99 [0.64-1.51],0.948352585810768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,19508,30,1.41 [0.74-2.67],0.2924573554954675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,22075,32,0.76 [0.50-1.14],0.1832078024021872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,19561,30,0.60 [0.34-1.07],0.0819480499931704
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,19561,30,0.59 [0.28-1.24],0.1632117953718183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,22482,31,1.55 [0.31-7.80],0.5969025403461836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,22025,31,0.70 [0.43-1.16],0.1673668533176932
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,18973,28,1.29 [0.78-2.15],0.3243314972285334
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,19567,30,2.00 [1.61-2.49],3.7223590190333756e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,22787,33,3.27 [1.38-7.72],0.0068883319723067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,22689,32,1.70 [0.78-3.70],0.1831032677998494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,22672,32,0.93 [0.47-1.82],0.8251638492501328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,19118,29,1.34 [0.89-2.01],0.156901368872247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22655,32,0.96 [0.59-1.56],0.8749420488494019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19561,30,0.72 [0.39-1.35],0.3101314473971427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,19061,30,0.92 [0.52-1.65],0.7812407235364651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,19596,31,0.89 [0.61-1.29],0.5378295928243473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,22588,34,0.86 [0.61-1.20],0.3664559235355328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,19061,30,1.14 [0.54-2.41],0.7271352340303112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,22656,33,0.73 [0.53-1.02],0.0651203375662445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,19637,31,1.23 [0.69-2.19],0.4900647595517313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,19255,29,0.77 [0.56-1.06],0.1089111790478328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,22436,31,1.70 [1.04-2.77],0.0348664554298437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19169,30,0.39 [0.12-1.26],0.1146771233002426
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',19628,31,1.93 [0.99-3.74],0.0526247384902746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,19070,31,1.37 [0.93-2.02],0.1125530641611394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,19255,29,1.17 [0.61-2.21],0.640469863328093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,19567,30,0.74 [0.30-1.80],0.5046501597902568
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,19561,30,0.96 [0.61-1.50],0.846027859653584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,19169,30,0.73 [0.21-2.54],0.6167894853935507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,22588,34,1.05 [0.68-1.64],0.8122516408096967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],22106,33,1.19 [0.64-2.21],0.5780034202446902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",22595,33,1.33 [0.62-2.87],0.4645514581258014
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,19671,31,1.08 [0.64-1.83],0.7720811330875188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,19637,31,1.04 [0.45-2.38],0.9346398269928806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,22075,32,1.53 [0.64-3.64],0.3381892163660105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,22678,33,1.24 [0.78-1.97],0.3642209288269892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,22554,34,1.20 [0.53-2.76],0.6601371476661215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,22554,34,1.05 [0.48-2.29],0.9086205842609631
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19121,30,1.11 [0.59-2.08],0.7401949615850272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,19610,31,1.28 [0.31-5.31],0.7326828262628362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,19121,30,1.27 [0.35-4.69],0.71511673345681
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19637,31,2.11 [1.19-3.75],0.0109390956682406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,19637,31,0.98 [0.54-1.78],0.938317570233678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,22656,33,0.80 [0.53-1.20],0.2789075689423069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,22577,34,0.58 [0.19-1.76],0.337248140696355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPART,Spartin,19255,29,0.71 [0.44-1.16],0.1731729433352953
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,19667,31,3.40 [1.31-8.83],0.0118166301611531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,22595,33,0.93 [0.44-1.97],0.856899708788928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,19255,29,0.88 [0.34-2.28],0.7889429430408346
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,22547,32,0.74 [0.44-1.23],0.2451638277383456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,22595,33,0.43 [0.16-1.16],0.0944874074371284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,22787,33,1.64 [0.92-2.92],0.0948116284714613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,19070,31,0.74 [0.25-2.14],0.5734340530676737
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,22531,33,4.54 [2.48-8.32],1.0060592967355091e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,22689,32,0.76 [0.38-1.55],0.4548136567990964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,19567,30,1.02 [0.77-1.34],0.895058917093244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,22436,31,0.75 [0.21-2.67],0.6621995067708739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,22622,32,1.29 [0.49-3.36],0.6067060795207884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,22488,34,1.98 [0.85-4.62],0.1123507786425249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,22819,34,1.36 [0.71-2.60],0.3478645474300853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19118,29,1.28 [0.62-2.62],0.5050587049972892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,18973,28,0.80 [0.39-1.67],0.5588655537741614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,19289,30,0.42 [0.21-0.83],0.0136212272897875
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,19628,31,0.98 [0.61-1.58],0.9381666987263136
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,22160,32,0.80 [0.56-1.14],0.2159820573777344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19061,30,3.39 [2.22-5.18],1.5296747195473592e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,19628,31,0.35 [0.09-1.29],0.1141048537403894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,22616,33,0.80 [0.63-1.03],0.086708308839024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,22482,31,2.41 [1.76-3.30],4.795648130585625e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,22547,32,1.11 [0.78-1.59],0.5592482968484103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,19667,31,0.98 [0.34-2.83],0.975546220812982
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,22025,31,0.83 [0.44-1.54],0.5455197998601906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19118,29,0.80 [0.26-2.40],0.6869833060701902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22554,34,1.14 [0.86-1.51],0.3464596826272621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22650,34,1.41 [0.68-2.93],0.3512252670262094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,18973,28,0.41 [0.10-1.69],0.2180900030209898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,19567,30,0.99 [0.50-1.95],0.9712492688629712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,19255,29,0.79 [0.42-1.48],0.457253207148404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22482,31,1.43 [0.74-2.78],0.2879082800789948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22858,34,1.19 [0.42-3.36],0.7427149721806405
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19118,29,1.14 [0.60-2.17],0.6782297267354358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,19662,30,1.74 [0.52-5.74],0.3669647289267232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,19561,30,0.32 [0.10-1.03],0.055146171330948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,22388,31,0.84 [0.51-1.39],0.502042722387007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,19118,29,1.15 [0.72-1.82],0.5653227408746959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,22482,31,0.86 [0.68-1.08],0.19225728115756
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,18973,28,0.85 [0.46-1.56],0.5930462983787805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,22785,32,1.82 [1.43-2.32],1.3426594724660623e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,22562,33,3.11 [0.89-10.89],0.0766645736030683
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,19061,30,0.49 [0.24-1.02],0.0558947081788687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,22565,33,0.87 [0.54-1.40],0.5609797459265957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,22185,33,0.80 [0.52-1.23],0.3067787450084068
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,22025,31,0.81 [0.48-1.37],0.4315532037900865
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,22588,34,0.83 [0.58-1.18],0.2909079497914371
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",18973,28,0.77 [0.49-1.22],0.2667829957091456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,22075,32,0.63 [0.33-1.19],0.1561327358351565
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,19121,30,0.49 [0.16-1.56],0.2285257418497323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,19628,31,0.49 [0.15-1.65],0.2521537157547294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,22482,31,0.89 [0.50-1.57],0.6829964010278389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,19118,29,0.98 [0.41-2.34],0.9620802117911716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,22075,32,0.99 [0.63-1.57],0.9736091389103652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,19118,29,2.16 [1.11-4.22],0.0235385013812464
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,22547,32,0.83 [0.43-1.61],0.588903880533064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,19637,31,0.69 [0.45-1.06],0.0927845014454128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,22075,32,0.53 [0.23-1.25],0.1479852114694287
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,19567,30,1.40 [0.64-3.05],0.4036196191710517
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,22075,32,0.85 [0.58-1.26],0.4172872505949311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,22785,32,0.79 [0.63-0.99],0.0448364262828914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,22547,32,1.40 [0.90-2.19],0.1366506168431986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,19118,29,1.07 [0.68-1.69],0.7638716445010831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22785,32,0.58 [0.35-0.96],0.0332388783896234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",19637,31,1.11 [0.66-1.88],0.6822304138105257
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,22185,33,0.75 [0.40-1.38],0.3519123954715077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,22595,33,1.28 [0.45-3.65],0.6481427438838574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,19561,30,1.29 [0.64-2.59],0.4706911070075398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,19137,27,2.70 [0.91-8.02],0.0731454698799126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,19121,30,1.02 [0.58-1.77],0.9508993752930768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,19567,30,2.21 [1.61-3.02],7.380663501893772e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,19255,29,0.54 [0.27-1.11],0.0944733286692459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19061,30,0.94 [0.50-1.76],0.8377039927407419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,19628,31,0.84 [0.32-2.23],0.7277778826539099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,19667,31,0.85 [0.52-1.39],0.5207421064291997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19289,30,0.87 [0.62-1.22],0.413640211265475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,22482,31,0.82 [0.63-1.07],0.1518667287623452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,20055,25,0.73 [0.21-2.52],0.6216735483678038
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,19561,30,0.93 [0.37-2.30],0.8718652021852611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,22482,31,0.70 [0.28-1.77],0.4537587675321818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,18973,28,0.79 [0.42-1.50],0.467962479464958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,19578,29,1.32 [0.62-2.81],0.4697405473548606
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,22160,32,0.91 [0.58-1.46],0.7075241876726615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,19289,30,0.37 [0.15-0.93],0.0344752501650131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,22025,31,0.77 [0.50-1.16],0.2123981233223782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19121,30,0.92 [0.57-1.50],0.7398008138925218
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19561,30,0.75 [0.28-2.00],0.5637234236624498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,19628,31,1.43 [0.89-2.30],0.1406603706767065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,22025,31,1.50 [0.89-2.53],0.1309578475826167
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,22482,31,0.81 [0.57-1.17],0.2656813381435327
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,22547,32,0.91 [0.61-1.37],0.6642726547700271
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,19255,29,0.89 [0.58-1.35],0.5687473866711859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,22436,31,0.83 [0.61-1.13],0.2412948288064286
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,22436,31,0.79 [0.53-1.18],0.2538524402206515
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,22075,32,0.78 [0.54-1.13],0.1862083358898596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,19121,30,0.59 [0.21-1.63],0.3078403759949506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,22397,31,2.90 [2.33-3.61],1.0765518981164658e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,22185,33,0.86 [0.54-1.36],0.5142611535521443
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,19260,30,0.61 [0.21-1.73],0.3503709303671419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,22819,34,1.48 [0.61-3.61],0.3889680004297285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,19667,31,38.52 [13.77-107.72],3.440524066842115e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,19289,30,0.97 [0.52-1.81],0.9153981116876244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,19667,31,0.73 [0.23-2.36],0.5990005453399421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,22025,31,0.89 [0.70-1.12],0.3235999209165721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",19121,30,0.99 [0.41-2.42],0.9882578058643242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,19561,30,1.57 [1.16-2.11],0.0031474216512059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,22025,31,0.96 [0.65-1.41],0.8298593684531786
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,19070,31,1.32 [0.67-2.62],0.4208811043932753
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,22656,33,5.14 [1.35-19.65],0.0166000428888919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,19118,29,1.49 [0.53-4.22],0.4485215391951441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,19253,30,0.95 [0.65-1.39],0.7796114573750944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,19121,30,0.85 [0.34-2.11],0.7318824477795355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,19289,30,1.49 [0.89-2.50],0.1259709461823854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,19696,31,0.64 [0.31-1.36],0.2482516295197884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,19061,30,1.03 [0.59-1.82],0.912407984576368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,22483,31,1.17 [0.80-1.72],0.4235660522500493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,22650,32,0.95 [0.53-1.69],0.8577318239184747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,22546,34,1.03 [0.55-1.92],0.9380189521510922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,22505,34,0.43 [0.15-1.19],0.1050341730126915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,22584,33,1.62 [1.06-2.47],0.0260630916123631
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,22662,34,1.49 [0.70-3.13],0.2977791554519597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,19561,30,1.11 [0.85-1.46],0.4380839343026887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,22547,32,1.35 [0.72-2.55],0.3492266285654102
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,22795,33,0.79 [0.34-1.81],0.5720387683738333
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,19561,30,1.18 [0.65-2.13],0.5886672983038006
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,22428,34,1.07 [0.35-3.29],0.9063874699506764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,19118,29,1.72 [0.54-5.48],0.3587895550249161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,22656,33,2.12 [0.94-4.75],0.0686729580677051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,22858,34,1.26 [0.49-3.24],0.6264326613491098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,22558,34,1.24 [0.84-1.83],0.2826502944517916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,19671,31,6.11 [2.42-15.41],0.0001274846581299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,18935,28,1.06 [0.73-1.53],0.7500556883190871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,22588,34,9.15 [4.63-18.10],1.9416014412267364e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,22595,33,1.39 [0.62-3.10],0.4196773321602718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,22573,34,0.88 [0.45-1.72],0.6991305973827875
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,22485,34,3.16 [1.55-6.46],0.0016080223601911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,22185,33,0.68 [0.30-1.56],0.3669237006825983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,19070,31,1.03 [0.78-1.37],0.8230425081417869
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,18974,29,1.51 [0.62-3.64],0.3606572692201911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,19534,30,0.77 [0.52-1.16],0.2099565519710134
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,22785,32,3.40 [1.30-8.87],0.0122836650043799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,21944,33,0.95 [0.73-1.24],0.7122089322405487
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,22858,34,3.88 [1.35-11.17],0.011880790131642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",21977,31,2.00 [1.27-3.16],0.0029446988574212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19289,30,1.55 [0.78-3.11],0.2125317079540582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22650,34,2.52 [1.35-4.72],0.0037550286181269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19667,31,0.96 [0.41-2.28],0.9279244620859902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19628,31,1.00 [0.67-1.49],0.9917350229355238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,22315,34,1.28 [0.44-3.70],0.6527604015312483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,19667,31,0.45 [0.09-2.38],0.3489770529953606
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,22689,32,0.76 [0.59-0.98],0.0366921644265871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,22595,33,0.31 [0.14-0.70],0.0047075507987468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,22513,34,3.30 [0.93-11.75],0.0650019904999704
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,22656,33,0.89 [0.61-1.30],0.557478065544804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,19061,30,1.34 [0.72-2.48],0.361338805418552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",19289,30,1.03 [0.47-2.24],0.94608681695613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,19118,29,2.74 [1.02-7.37],0.0450082452715724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,19289,30,1.09 [0.24-4.94],0.914427376603316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,22835,33,1.32 [0.77-2.27],0.3074981341309918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,19118,29,0.74 [0.20-2.67],0.6414455560403914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19121,30,0.88 [0.45-1.75],0.7232813920203456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,19289,30,0.55 [0.25-1.18],0.1223704963502557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,19070,31,0.35 [0.09-1.31],0.1175975822435595
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,19070,31,0.82 [0.40-1.67],0.5774362723606787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,19567,30,0.79 [0.57-1.11],0.1758128506388457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,19561,30,0.62 [0.36-1.07],0.0838460616888648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,19169,30,1.08 [0.63-1.87],0.7684502791557923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,19637,31,1.48 [0.84-2.59],0.1727400409970853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,18973,28,1.01 [0.42-2.42],0.9859407361456748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,19061,30,0.80 [0.47-1.38],0.4278645884172627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,19587,31,0.49 [0.21-1.17],0.1082578422703122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,22482,31,0.88 [0.62-1.25],0.4685580662601721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,22328,31,1.36 [0.59-3.18],0.4709218860734974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,22595,33,1.26 [0.84-1.90],0.2612829041918859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,22650,34,1.26 [0.68-2.34],0.4625793863586509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,22144,33,1.76 [1.22-2.54],0.00245024356876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19567,30,0.93 [0.43-2.00],0.8553249781281129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22160,32,0.73 [0.30-1.79],0.4969642733872711
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19255,29,0.62 [0.33-1.15],0.1297688902020025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22436,31,2.58 [1.62-4.13],6.972579870360061e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22436,31,1.55 [1.19-2.02],0.0010236234303534
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22620,33,0.72 [0.40-1.30],0.2756282864795273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22835,33,2.26 [1.13-4.54],0.0213292726721133
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22580,32,0.86 [0.28-2.60],0.7909390984094329
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22656,33,2.31 [1.04-5.11],0.0391641223841323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22622,32,2.15 [1.53-3.02],9.294956112301822e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22160,32,4.07 [3.12-5.30],4.256405512379527e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22622,32,1.64 [0.60-4.45],0.3353737609216556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19255,29,6.57 [3.14-13.74],5.878259997880561e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22787,33,2.58 [1.09-6.10],0.0308670450027356
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22595,33,3.14 [1.28-7.67],0.0121827039468826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22595,33,0.43 [0.14-1.29],0.132759701442787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22785,32,1.91 [0.63-5.86],0.2555270938855981
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22795,33,5.35 [3.17-9.03],3.622878661025289e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22436,31,1.55 [0.97-2.49],0.0692954502950362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22785,32,2.63 [1.64-4.21],5.9762557759786655e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22436,31,2.26 [1.75-2.93],5.198987674381516e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,22835,33,0.63 [0.19-2.09],0.4506171031319803
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,22547,32,1.81 [1.08-3.01],0.0237948193374239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,22835,33,0.51 [0.17-1.49],0.216082470668059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,22689,32,0.77 [0.45-1.29],0.3197372049796975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22819,34,0.60 [0.35-1.02],0.0587235817916018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,22436,31,0.77 [0.43-1.36],0.3610387796210069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,19662,30,3.87 [2.00-7.50],5.964205686367415e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,19628,31,1.14 [0.78-1.67],0.4882210530996603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,19662,30,0.56 [0.26-1.25],0.156867756094052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",22185,33,0.92 [0.65-1.30],0.6330414966507417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,19289,30,0.85 [0.31-2.36],0.7564110080035876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,22436,31,0.38 [0.19-0.77],0.0065515747668009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,22595,33,1.06 [0.32-3.55],0.9254845525213444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19667,31,1.06 [0.68-1.64],0.7945899040033286
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,19567,30,1.03 [0.75-1.43],0.836407536617958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",18973,28,1.12 [0.57-2.18],0.7423675039076019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,19118,29,1.26 [0.83-1.93],0.2827609581462146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,19169,30,1.36 [0.80-2.30],0.2536471701191011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,22075,32,1.99 [1.14-3.45],0.0149104390500499
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,19118,29,1.61 [1.12-2.30],0.0097161203960714
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,18832,28,0.99 [0.50-1.98],0.9783173546013162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,22185,33,0.33 [0.08-1.38],0.1278629960799011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,19121,30,0.99 [0.36-2.73],0.9852926620244994
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,19121,30,1.02 [0.44-2.33],0.9708543857724052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,19255,29,0.77 [0.56-1.05],0.0980563380373502
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,19667,31,4.60 [1.45-14.67],0.0097809774444433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,19070,31,0.93 [0.40-2.16],0.8680752480600666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,22075,32,0.94 [0.61-1.46],0.7872363793744708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,22436,31,0.72 [0.33-1.59],0.4201817625831182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,19289,30,0.56 [0.34-0.90],0.0173911620849873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,22025,31,0.50 [0.18-1.36],0.1727513033458142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,19070,31,1.65 [1.17-2.31],0.0038754906687741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,18973,28,0.91 [0.49-1.69],0.7700046185669034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,22798,33,0.77 [0.44-1.37],0.3807916326491608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,19637,31,0.80 [0.29-2.19],0.6618461965180213
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,19118,29,1.88 [0.72-4.92],0.1988389063379108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,22160,32,0.81 [0.46-1.45],0.4820493853260048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,22547,32,1.07 [0.69-1.66],0.7554908834690424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",19118,29,1.41 [0.67-2.96],0.3594045191709328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19070,31,0.69 [0.28-1.70],0.419360699724756
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19289,30,0.78 [0.49-1.25],0.3052830068404601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,19662,30,1.07 [0.67-1.72],0.7782155318644642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,22580,32,2.15 [1.23-3.75],0.0069074293627549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,19671,31,0.76 [0.39-1.48],0.4160084532593375
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,22595,33,8.12 [4.77-13.81],1.174231756492278e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,22787,33,1.00 [0.61-1.64],0.9965098086711072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,22547,32,0.85 [0.59-1.21],0.3536357316244274
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,19246,30,0.93 [0.54-1.62],0.8069377064461962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19567,30,0.85 [0.62-1.18],0.3450471095977414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,18973,28,1.28 [0.78-2.10],0.3288645877318882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,19121,30,0.56 [0.34-0.94],0.0281637319843107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,22547,32,0.83 [0.58-1.21],0.3391639173909452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,19561,30,0.89 [0.59-1.34],0.5758420123922654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,19070,31,0.61 [0.26-1.45],0.2599892724712099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,19118,29,1.46 [1.11-1.93],0.0073893626157196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,19637,31,0.91 [0.54-1.55],0.7407194730054274
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,22588,34,1.05 [0.74-1.50],0.776683347385613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,22185,33,0.53 [0.27-1.07],0.0755263690159089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,19070,31,0.85 [0.35-2.07],0.7147482937022963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,22185,33,0.78 [0.24-2.50],0.6750963227469576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,19070,31,0.95 [0.47-1.89],0.8732064119060543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,19061,30,0.72 [0.43-1.21],0.2194571048897494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,19567,30,1.09 [0.78-1.51],0.6132220014817302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,19118,29,0.55 [0.21-1.44],0.2212484371660872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,21987,31,0.94 [0.61-1.44],0.759348772321268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,19121,30,1.14 [0.57-2.28],0.7045462954482793
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTN,Titin,19070,31,1.00 [0.60-1.68],0.9984762432620008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,19470,30,0.75 [0.39-1.44],0.3878814364522693
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,19061,30,2.43 [0.99-5.99],0.0538471237093633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,19662,30,0.86 [0.56-1.32],0.4893263939098775
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,19289,30,0.48 [0.22-1.04],0.064117688989478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,22436,31,1.10 [0.76-1.58],0.624907223865212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,19329,30,0.82 [0.35-1.88],0.6342455116713054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,22656,33,0.78 [0.45-1.32],0.3486350529045807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,22785,32,0.80 [0.49-1.29],0.3520245778382868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,19628,31,0.91 [0.47-1.77],0.7766575680268041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,19025,30,0.40 [0.19-0.82],0.0126110463631827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22595,33,0.70 [0.35-1.40],0.3122447034000886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,22442,34,1.07 [0.67-1.69],0.7861638094735071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,22588,34,1.18 [0.40-3.45],0.7668214484563538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19118,29,1.38 [0.76-2.50],0.2843758145875196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,22482,31,1.10 [0.45-2.69],0.8294710595539412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,19561,30,1.33 [0.46-3.87],0.6017425431378651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19667,31,1.07 [0.61-1.87],0.8124475719581534
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19118,29,1.23 [0.73-2.06],0.4350033145395729
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,19070,31,1.22 [0.65-2.30],0.5367117421302031
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,19255,29,0.84 [0.49-1.44],0.5322474246476101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19567,30,0.78 [0.61-1.01],0.0549917323807012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,19070,31,0.57 [0.31-1.07],0.0783084663690355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,19070,31,1.01 [0.39-2.59],0.9836465251225524
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,22436,31,2.14 [1.02-4.49],0.0428798427184159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,22794,34,0.72 [0.43-1.20],0.2074400138706784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,19118,29,1.12 [0.30-4.25],0.8637482953616711
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,18973,28,0.72 [0.35-1.46],0.3641319953922894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,19561,30,1.43 [0.61-3.31],0.4097474871568312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,19667,31,1.30 [0.93-1.83],0.1260143817325149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,19061,30,1.34 [0.74-2.45],0.3340573979669244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,19261,30,0.97 [0.50-1.86],0.9238474619391006
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,19255,29,0.92 [0.55-1.53],0.7393705970972704
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,19121,30,1.38 [0.95-2.02],0.0912350213499905
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,22482,31,0.82 [0.58-1.17],0.273248322802612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,19561,30,0.92 [0.56-1.50],0.7343853483542759
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,19628,31,2.25 [1.55-3.26],1.822228859160549e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,19070,31,1.10 [0.76-1.60],0.6033848086488338
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,22185,33,1.03 [0.75-1.42],0.8625230027986408
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,22075,32,1.32 [0.82-2.13],0.2531968290531935
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,22185,33,0.60 [0.29-1.24],0.1710317117776496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,19118,29,0.94 [0.63-1.42],0.7755974416648564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,22547,32,0.80 [0.54-1.19],0.2773174136991984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,22202,33,0.84 [0.26-2.66],0.7659672086326615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,19671,31,0.79 [0.49-1.30],0.3563883799591335
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22482,31,2.07 [0.45-9.58],0.3506571153376675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,19061,30,0.89 [0.62-1.28],0.5413597188678845
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,22613,34,4.90 [2.10-11.45],0.0002448388713337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,22785,32,1.09 [0.39-3.07],0.8695199995288703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,18973,28,0.92 [0.58-1.47],0.7259431103873328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,22766,33,0.87 [0.51-1.49],0.6169687652136082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,19118,29,0.78 [0.44-1.38],0.3937468748183758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,22656,33,0.64 [0.37-1.11],0.1100019582341943
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,22795,33,0.84 [0.33-2.10],0.7052096827981513
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,19637,31,2.01 [0.68-5.97],0.2071652840429267
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,22185,33,0.92 [0.72-1.18],0.5278567042760594
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,19169,30,0.82 [0.19-3.50],0.7861226285485765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,19667,31,0.96 [0.38-2.43],0.932447580909222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,22482,31,0.88 [0.57-1.36],0.5611420082370824
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,19671,31,0.92 [0.58-1.46],0.7248311112925558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,22482,31,1.02 [0.51-2.06],0.9489394836789588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,19289,30,0.70 [0.39-1.26],0.2379951129736933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,22482,31,0.83 [0.55-1.26],0.3841729083885995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,19561,30,0.72 [0.49-1.06],0.0950108607671109
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,22482,31,0.84 [0.55-1.29],0.4287883872042258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,19561,30,1.26 [0.54-2.91],0.5944222476868382
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19070,31,0.68 [0.22-2.10],0.4998050671647108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,19561,30,1.02 [0.56-1.85],0.945973437236174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,22562,33,2.00 [1.00-4.02],0.0502816471136784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22553,34,0.83 [0.50-1.40],0.4873740736597716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,19628,31,0.89 [0.35-2.30],0.814633494495314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,22025,31,0.83 [0.42-1.62],0.5864328244902737
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,19289,30,0.78 [0.30-2.02],0.6116709862033953
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22185,33,0.69 [0.38-1.26],0.2302088691921933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22785,32,0.76 [0.49-1.19],0.2307951106138649
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,22075,32,0.90 [0.32-2.49],0.8371286876143945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19255,29,0.80 [0.42-1.53],0.5072144738770504
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,22748,33,0.76 [0.36-1.60],0.4712376786271317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,18973,28,0.89 [0.52-1.50],0.6514034358661542
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,22353,31,1.09 [0.47-2.52],0.8380215149375709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,19637,31,0.89 [0.40-2.00],0.7838668390703035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,22858,34,1.45 [0.97-2.18],0.0703269635376518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",22595,33,2.45 [1.17-5.13],0.0176243958064118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,22160,32,0.86 [0.53-1.39],0.536567293196657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,22185,33,0.91 [0.65-1.28],0.586849562369527
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,22025,31,0.73 [0.52-1.01],0.0589449253775052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,19628,31,0.95 [0.60-1.51],0.8411060340005603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,19118,29,0.66 [0.32-1.36],0.2647086144435103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,19561,30,2.93 [2.18-3.95],1.4704738166064148e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,19176,30,0.54 [0.22-1.35],0.189264993313115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,22759,33,0.94 [0.58-1.51],0.7890290809873151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,21421,31,2.28 [1.15-4.56],0.0190219134345766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22374,31,1.26 [0.58-2.74],0.561850702664888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22622,32,0.84 [0.34-2.08],0.7065542126641859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,22787,33,1.26 [0.52-3.06],0.6069119869614961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,22160,32,0.98 [0.32-3.00],0.9749496969242144
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22436,31,0.92 [0.51-1.67],0.7795240756108626
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,22787,33,1.60 [1.13-2.26],0.0076852269164029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,22743,33,1.23 [0.44-3.40],0.6934737951048996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,19118,29,1.23 [0.67-2.24],0.5031758162417476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,22656,33,1.14 [0.80-1.63],0.4589625106871131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,22025,31,1.47 [0.70-3.10],0.3098610422029685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,19628,31,1.66 [0.48-5.70],0.4230828067269427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19567,30,0.79 [0.63-1.00],0.0462501184511624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,22482,31,0.81 [0.61-1.08],0.1528912808817766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,19561,30,1.75 [0.71-4.30],0.2238575358374807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,19070,31,1.14 [0.67-1.95],0.6314906234790337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,22160,32,0.85 [0.58-1.25],0.4051639873953547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,19255,29,0.84 [0.51-1.38],0.4948984649383317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,19118,29,1.41 [0.45-4.42],0.557928576115685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,19118,29,2.32 [1.60-3.35],7.757082257579499e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,22075,32,0.64 [0.39-1.07],0.0895915988050777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,22185,33,2.24 [1.55-3.22],1.68149818710387e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,19070,31,1.13 [0.70-1.85],0.6109539201680487
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,19567,30,0.81 [0.55-1.20],0.2994764375840625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,19628,31,1.93 [1.43-2.60],1.859317878758619e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,19118,29,1.53 [0.85-2.77],0.158333278209911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,19289,30,1.11 [0.67-1.85],0.6905732292581843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,19561,30,0.74 [0.43-1.27],0.2749674520412835
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,19567,30,1.21 [0.75-1.98],0.4356798384293741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19561,30,0.61 [0.30-1.24],0.1747771481925981
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,19169,30,0.92 [0.81-1.04],0.1721155370886937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,18973,28,0.34 [0.07-1.65],0.1825566953691771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,19061,30,0.38 [0.20-0.75],0.0050990237615243
